ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0032693;negative regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.943860283624253;0.002184000309729388;0.6782296504172152;[IL23A, PDCD1LG2, AGER, JAK3]
GO:0032330;regulation of chondrocyte differentiation;6.0;0.7671156992804218;0.7066781622303554;9.34084218004034;56.03372000150423;5.948432231191374;0.001875398181376348;0.6273234135236593;[SHOX2, SOX6, GLG1, RUNX2, RELA, TGFBR1]
GO:0060129;thyroid-stimulating hormone-secreting cell differentiation;8.0;1.0;0.875;9.628524252492122;56.29999269909438;8.67846133901236;0.0018843100889348208;0.8188169164668168;[BMP2]
GO:0035280;miRNA loading onto RISC involved in gene silencing by miRNA;8.0;1.0;0.875;9.628524252492122;67.69457493929042;7.8311634786251565;0.002265676502055942;0.7754860644832351;[DICER1]
GO:0000731;DNA synthesis involved in DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.369013057007038;574.6870345922199;5.8067817141283475;0.019234257863048946;0.6719590869034888;[RFC5, CDKN2D, RFC3, WRN, NPLOC4, RFC4, PCNA, RFC1, RFC2, POLE2, WRNIP1, POLH]
GO:0045648;positive regulation of erythrocyte differentiation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;358.80145150428314;6.409777797693995;0.012008761681506467;0.7027963346592216;[ARNT, NCKAP1L, ACVR1B, SMAP1]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[AGPAT5, ARL11, COL24A1, XRCC5, PAPD4, SFRP1, SIN3A, HYAL2, KIT, HOXB4, PTPN6, SSBP3, MIXL1]
GO:0007016;cytoskeletal anchoring at plasma membrane;6.0;1.0;0.8231203125901445;9.628524252492122;66.89368938276097;7.474488534686424;0.002238871583229107;0.7053660038532718;[JUP, TLN2, TLN1]
GO:0060128;corticotropin hormone secreting cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;9.083926447120524;7.050676185779127E-4;0.714552420951524;[BMP2]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[DUSP5, MAP4K2, CD74, DBNL, PDE6H, SYK, THBS1, MAPK8IP3, SOD1, ERN1, P2RX7, BMP2, KARS, TAOK2, KIT, MADD, RIPK1, CCL19, MAP3K5]
GO:0048247;lymphocyte chemotaxis;7.0;0.7671156992804218;0.7344772148974115;9.303101852057495;94.37808318069546;5.926926025970411;0.003158749509297446;0.6540226378555745;[HSD3B7, CXCL9, CXCL11, CCL3L1, CCL20, CCL5, CCL3, CCL2, CCL19, PIK3CG, CCR2]
GO:0001942;hair follicle development;4.0;1.0;0.75;9.628524252492122;22.36266381479647;6.166155715036245;7.48458232790436E-4;0.5653374900225189;[LAMA5, NSDHL, FZD6, HOXC13, LDB2, APCDD1, ACVR1B, RELA]
GO:0060804;positive regulation of Wnt signaling pathway by BMP signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;475.65903384128745;9.777073627680469;0.01591987979732979;0.9481203125901445;[BMP2]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[ITGB1, ELL, CHD7, ACVR1B, RIC8A, FLCN, CCNB1, FUT8, RXRA, SIN3A, SOX8, MGAT1, ATP7A, SOX6, WDTC1, MBNL1, ENDOG, UBE2B, ANGPT1, TGFBR1, MIB1, BMP2, ALS2, MAFF, MYH9, CCM2, EIF4E2, APBA3, SEC24C]
GO:0006958;complement activation, classical pathway;8.0;1.0;0.875;9.628524252492122;171.02669507306572;4.7081694254602375;0.005724109570062889;0.6157760033703056;[C3, CR2, CR1, C1QBP, C1QC, C2]
GO:0030948;negative regulation of vascular endothelial growth factor receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;297.5747140953686;7.474488534686424;0.00995955788091634;0.7331650565203278;[PDCD6, NEDD4]
GO:0007260;tyrosine phosphorylation of STAT protein;10.0;1.0;0.9152410118609203;9.628524252492122;339.94073760219794;7.57984905034425;0.011377510560744174;0.8028748447945538;[JAK3]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[ARHGEF11, RTKN, ROCK2, ARHGAP1, WAS, MYO9B, RHOC, ARHGAP6, RHOB, RHOT2, RHOT1, COL1A2, CDC42EP4, ARHGDIB, CFL1, TAX1BP3, ARHGEF1, RHOU]
GO:0045416;positive regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.474488534686424;0.027942676825076673;0.7572456912631272;[TLR8, TLR7]
GO:0051895;negative regulation of focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;270.76229412472316;7.069023426578259;0.009062170314110184;0.7365101867784198;[RCC2, DLC1, PTEN, THBS1, ARHGAP6]
GO:0050680;negative regulation of epithelial cell proliferation;6.0;0.7307253602413294;0.6884829927108091;8.690254613899192;65.19530579150691;4.989581884898423;0.0021820282128758306;0.5782877622231366;[CDKN1C, CAV1, SERPINF1, ATPIF1, EAF2, PTEN, IFT122, WFDC1, PTPRK, THBS1, WDR13, TGFBR1, SFRP1, CDK6, SFRP2, NFIB, CCL2]
GO:0035024;negative regulation of Rho protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;340.00127024396755;6.832634648514029;0.011379536533788362;0.7646622655359331;[ITGB1, FLCN, DLC1, MET]
GO:0070507;regulation of microtubule cytoskeleton organization;7.0;0.6073376606709605;0.6545881955926808;8.242229891372231;33.71079736555127;4.584116776790259;0.0011282700500770656;0.5853513104054853;[PHLDB1, ROCK2, VPS4B, CCNF, ARL2, CIB1, BRCA1, BICD1, SENP6, TPR, NUP62, CEP70, ABL1, RAE1, CLASP1, MARK2, PDCD6IP, RANBP3, MAP1S, EML2, NSFL1C, CYLD, STAG1, STAG2, FES, CENPJ, CHMP4B, MAPRE3, MAPRE1, FKBP4, MET, PAFAH1B1, MCPH1, MDM1]
GO:0006383;transcription by RNA polymerase III;10.0;0.8436909121759173;0.837086467948879;9.499312521012115;583.8786478812184;6.113511981550823;0.01954189288791682;0.7278862989048107;[GTF3C1, IVNS1ABP, ZNF143, TBP, ELL, POLR3B, POLR3C, POLR3E, POLR2E, POLR2K]
GO:0031581;hemidesmosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;36.796901128588246;7.292166977892469;0.0012315591657128446;0.6960420709600095;[CD151, LAMB3, ITGB4, LAMC1]
GO:0008203;cholesterol metabolic process;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;82.64786032185484;5.058574756385375;0.0027661495067272364;0.581816060879476;[SCARB1, CETP, PCSK9, EBP, NSDHL, RXRA, CYB5R3, FDXR, SCAP, APOL1, SCARF1, LBR, APOL2, HSD3B7, STARD3, MBTPS1, G6PD, GGPS1, ERLIN2, CEL, ACLY, SQLE, SOAT1, SNX17, CAT, NFE2L1]
GO:0048812;neuron projection morphogenesis;7.0;0.6547035408479693;0.6782711356811852;8.502512989635898;62.99970935475633;4.360973225476049;0.002108543576046295;0.5739397388140403;[ITGB1, NCKAP1, TOP2B, C12orf57, PTEN, WASL, TRAK1, UGT8, NCKAP1L, NPTX1, ATP7A, NEFH, ZNF365, DBNL, RYK, MAP1S, BDNF, OMG, DICER1, GP5, DNM2, NR4A2, WEE1, LRFN4, SLC9A6, ALS2, CDK5, ADORA2A, NFIB, TAOK2, PAFAH1B1, PICALM]
GO:0097191;extrinsic apoptotic signaling pathway;6.0;0.8259837884571596;0.7361122068187242;9.223059144383958;51.05903939735586;5.277263957350204;0.0017089000984773794;0.5929998367869052;[DIABLO, TRADD, CIB1, ACVR1B, CASP8, BAG3, CASP3, MKNK2, CASP2, RIPK1, IL12A, ITGAV, BID, DEDD, APPL1, SIVA1, TNFRSF12A, EYA2, PARP2, CD70, G0S2, TNFRSF10B, TNFRSF10A, P2RX7, BAX]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[CCNK, ZWILCH, CCNF, GMNN, BUB1B, IPO7, RPS6KA2, MYC, ZNF207, EP300, IL12A, KNTC1, FBXO5, GTSE1, CDK5RAP3, TIPIN, PRKAB1, ERN1, TIMELESS, PRR11, MAX, XPC, CCNB1, RAD21, TPR, TP53BP2, ABL1, FANCI, ZBTB17, PRNP, PNPT1, CBX3, INTS3, MAD2L1BP, CNOT10, CDC7, ZWINT, CDK9, CNOT4, CNOT6, BMP2, STAG2, CDK6, CNOT7, CDK5, CNOT1, RHEB, CNOT3, CDK2, INTS7, ZNF655, CNOT8, EIF4G2, EZH2, MDM1, CDKN1C, TOP2B, BTG2, CDKN1A, BTG1, PTEN, BRCA1, PTPRK, PKD2, GPR132, CASP3, TIMP2, CASP2, TOPBP1, HORMAD1, HRAS, DACT1, H2AFY, EED, TGFBR1, RHOB, TFDP1, RBL1, ESPL1, TFDP2, CTDSP2, MCPH1, PPP1R15A, CDC123, PCNA, TP53I13, PRCC, THBS1, PPM1G, FZR1, TP53INP1, CCL2, RBBP7, E2F6, E2F7, E2F8, CDKN2D, TCF7L2, CDKN2C, DONSON, CENPF, WEE1, RAD51, FAP, RFWD3, TAOK2, BAX, MAD2L1]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[BMPR2, FOXG1, SHOX2, TWF2, PTEN, TRAK1, LRP8, CYB5D2, RAB21, NCKIPSD, CPNE1, TIMP2, DVL3, ECT2, SCARF1, MARK2, ARSB, ACTR2, TMEM30A, SEMA4D, TNFRSF12A, BDNF, SERPINF1, ADRA2C, RAB11A, NME1, SETX, BMP2, FES, RUFY3, CAPRIN1, RAPGEF1, RARA, CAMK1, ADNP, MEGF8, TRIM32, PAFAH1B1, EZH2]
GO:0042157;lipoprotein metabolic process;5.0;0.7586651285174919;0.6695735761196662;8.999915593069748;47.85814540089318;6.221725566191056;0.001601769057033345;0.6084203466557585;[APOL4, PCSK9, APOL1, APOL2]
GO:1905601;negative regulation of receptor-mediated endocytosis involved in cholesterol transport;10.0;1.0;0.9152410118609203;9.628524252492122;1047.1775299549363;9.777073627680469;0.03504808952900045;0.9152410118609203;[PCSK9]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[IL6, BMP2, BMPR2, SFRP2, TMEM119, FAM20C, RUNX2]
GO:0060389;pathway-restricted SMAD protein phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.212124270218933;0.006049650283656873;0.7438283705770736;[BMP2, TGFBR1]
GO:0006029;proteoglycan metabolic process;6.0;0.7140352122741334;0.6801379187272112;9.057979394024509;96.66964063832829;5.825829909099042;0.0032354458751365986;0.6210535250702663;[EXTL2, BMP2, BMPR2, CYTL1, B4GALT7, SGSH]
GO:0048814;regulation of dendrite morphogenesis;10.0;0.8259837884571596;0.8282329060895002;9.533214072687796;153.5143611256957;5.334422371190153;0.0051379875129217364;0.6880436199995941;[RAB21, FXR1, ACTR2, CDK5, SEMA4D, CAPRIN1, NEDD4, CFL1, PTEN, PDLIM5, LRP8, PAFAH1B1]
GO:0038092;nodal signaling pathway;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;30.596819335423756;7.292166977892469;0.0010240480078069776;0.769162383550154;[ACVR1B]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[OXTR, YWHAB, IL5RA, RASGEF1A, MYC, CTSH, ITGAV, HRAS, JAK3, MAP3K5, PDGFRB, DUSP5, MAP4K2, KSR1, FBXW11, PAQR3, IRAK4, GFRA2, SPTB, ITPKB, KARS, KIT, MET, HBEGF, PTGER4, CAMK2D, GPS1, GPS2, IL2RG, RASGRP4, RASGRP3, PABPN1, CCL5, CCL3, CCL2, NCAM1, MBP, RIPK1, SULT1A3, MAP3K3, MAP3K1, ANGPT1, NFKB1, MAPK13, SETX, PTPRA, TNIP2, TAOK2, CCM2, KRAS, TEK, CALM1]
GO:0006814;sodium ion transport;7.0;0.811012628672052;0.7564256795932265;9.310070521373587;34.16983994150393;4.629579150867016;0.001143633791982704;0.5876762583299873;[SLC12A2, SLC23A2, SLC20A1, SLC10A2, COMMD3, PKD2L1, ATP1B2, PKD2, SLC5A6, COMMD9, SLC9A6, SLC9A8, SLC38A6]
GO:0001920;negative regulation of receptor recycling;6.0;1.0;0.8231203125901445;9.628524252492122;203.33786122178435;8.390779266560578;0.006805535222898882;0.7522251544931926;[PCSK9]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CAMK2D, ENDOG, CACYBP, ARID1A, RASGRP2, TUBG1, PKD2, ITPKB, PPIF, CPNE1, CPNE3, CPNE2, ECT2, SLC25A24]
GO:0003308;negative regulation of Wnt signaling pathway involved in heart development;8.0;0.7763722522362496;0.7631861261181248;9.352270875863963;319.9618777477182;8.390779266560578;0.010708836101221256;0.8041048419030481;[BMP2]
GO:0034162;toll-like receptor 9 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;7.004484905440688;0.013811191226989502;0.8063299963962409;[TNIP2, TLR8, PIK3C3, TLR7, IRAK4, HAVCR2]
GO:2000272;negative regulation of signaling receptor activity;7.0;0.7248374789738407;0.7133381047441208;8.965230035081857;205.5464783691117;6.343086423195323;0.006879455651193543;0.6753050999230941;[ERRFI1, CLEC12B, PTEN, PCSK9, CHMP6, AGER]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[SYK, FES, ABL1, CSK, JAK3, IGF1R]
GO:1901016;regulation of potassium ion transmembrane transporter activity;9.0;0.6696747006330769;0.7310779754968275;8.996001693748612;134.63435111036006;5.885253329569843;0.004506090568614323;0.6972127541467594;[KCNG1, GAL, KCNE3, CAV1, NEDD4, NPPA, PTEN, OXSR1, ATP1B2, NETO2, KLHL24, DNM2]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[RIPK3, ROCK2, TRADD, TANK, NFKB1, RELA, NFKBIA, IRAK1BP1, NKIRAS1, TNIP2, TIFA, BCL3, SNIP1, TLR8, RIPK1, TLR7, CARD11, BIRC3]
GO:0005983;starch catabolic process;8.0;1.0;0.875;9.628524252492122;666.9679342199055;9.777073627680469;0.02232281652616981;0.875;[MGAM]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[PTGER4, MTPN, CD40, MAP3K1, TNFSF14, ITGA2, TNFRSF10B, TNFRSF10A, NFKB1, AQP1, CASP8, BAG3, NPPA, CASP2, TLR8, TLR7, LTBR]
GO:0001932;regulation of protein phosphorylation;8.0;0.49565848909023646;0.6228292445451182;7.636094087801916;109.02632868365667;2.531418560085934;0.00364901310371649;0.5044568628857964;[ERRFI1, CCNK, GMFB, CCNH, CCNF, RPS6KA4, PREX1, RPS6KA5, RASSF2, MYC, ARL6IP5, IL12A, TRIM27, EPHB4, CDK5RAP3, PRKCE, PAQR3, PRKCD, FLT3LG, MAPK8IP3, SFRP1, TWSG1, SFRP2, KARS, IL23A, DDIT4, JTB, MTCP1, TRIB3, EPHA1, IL22RA2, C3, HSPH1, RRAS, PRDX1, NCKAP1L, XRCC6, XRCC5, EIF2AK3, GDF1, PILRB, CCDC88A, EHD4, ARL2BP, QARS, PKIA, CALM3, CRIPAK, CALM1, CD24, CALM2, CCNJL, EZH2, CDKN1C, CDKN1A, CD40, KIF14, AKAP13, NNT, HYAL2, PBK, TIMP2, HRAS, HAVCR2, DUSP5, MAP4K2, DBNL, RIPK3, SYK, SPHK1, FCRL3, GFRA2, SIRT2, ITPKB, NCOR1, KIT, RAPGEF1, TLR8, MAPRE3, TLR7, ARHGEF5, PAFAH1B1, HBEGF, GPS1, GPS2, PPP2CA, SNX25, CCL19, CDKN2D, MAP3K3, CD74, CDKN2C, MAP3K1, CCL20, RYK, GPR55, CENPE, PDCL3, ITCH, NLRP12, TAOK2, CAMK1, NCF1, CD80, BCCIP, CIB1, PARK7, IPO7, IGF1R, NEK1, PDE8A, MAP3K5, PDGFRB, FBXO18, VRK2, CDC25A, ERN1, CCNE2, CCNE1, MADD, MYADM, ADNP, CCL3L1, PKMYT1, STK4, AGER, STK3, RAP1B, CCNB1, BAG4, STK38, ABL1, DVL3, RIPK1, ECT2, FAM83D, MARK2, PRNP, UBE2B, AMBP, BDNF, CAV1, TNFRSF10B, TNFRSF10A, CDK9, IL6, BMP2, COPS5, CDK6, CNOT7, SH3BP5L, CDK5, GNAQ, FGFR1OP, MNAT1, BCAR3, BMPR2, ITGB3, ITGB2, PTEN, PTPN22, PKD2, PIK3CG, DUSP14, CKS1B, FLCN, CASP3, NUP62, ITGAV, DACT1, FGA, KSR1, H2AFY, FGG, PLAUR, ZFP91, PPP2R5D, OXSR1, SENP2, ADRA2C, TGFBR1, DUSP22, ALS2, ADORA2A, CTDSP2, LCP2, CHMP6, MET, C9orf72, HDAC3, ROCK2, ITLN1, ACVR1B, LRP8, THBS1, CCL5, CCL3, CCL2, CSK, ZNF622, SASH1, TBX1, PDE6H, ANGPT1, SEMA4D, ATP2B4, SOD1, P2RX7, CD4, TNIP1, TAF7, CDK2AP1, BAX, KRAS, SPRY1, PTPN6, TEK, LTBR]
GO:0010768;negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage;13.0;1.0;0.9625549647676366;9.628524252492122;2472.6215018263188;9.083926447120524;0.08275641645124843;0.9271073857191605;[NEDD4]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[CD74, IL4R, FCER1G, EXO1, BCL3, PRKCD, TLR8, HLA-DQB1]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CXCL9, FCER1G, SYK, CCL3L1, CCL20, ITGB2, VAV1, PIK3CG, PREX1, CXCL11, CCL5, CCL3, CCL2, NCKAP1L, CCL19]
GO:0034158;toll-like receptor 8 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;9.777073627680469;0.013811191226989502;0.9481203125901445;[TLR8]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[PDCL3, BMP2, BMPR2, SP1, ITGB3, PDCD6, ARNT, TEK, TGFBR1]
GO:0038114;interleukin-21-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.697632086000634;0.00101047745553359;0.7445766281117727;[IL21R, IL2RG, JAK3]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1C, PPP1R15A, CDKN1A, CDC123, PKD2, THBS1, PPM1G, MYC, TP53INP1, ABL1, IL12A, HRAS, CDKN2D, PRNP, TCF7L2, CDKN2C, PNPT1, PRKAB1, TGFBR1, ERN1, CDK6, FAP, RHEB, PRR11, EIF4G2, MCPH1]
GO:0038113;interleukin-9-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;8.16763571524637;0.00101047745553359;0.7686126355688037;[IL2RG, JAK3]
GO:0008380;RNA splicing;8.0;0.7248374789738407;0.7374187394869203;9.182237149863703;117.47952805794706;3.8501476017100584;0.003931934079388465;0.5718967274016261;[EIF4A3, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, PTBP1, RAVER1, PCF11, C1QBP, ARL6IP4, DHX16, ZNF326, RBM5, DDX17, AQR, MBNL1, RBM15, BUD31, TFIP11, THOC2, SRRM1, THOC6, ERN1, PRPF4, PSPC1, THRAP3, PRPF3, ZNF638, SNRPG, CD2BP2, SLU7, SF1, SF3B5, SF3B2, WBP4, DDX23, PRCC, SUPT6H, PPP2CA, RNF113A, PABPN1, U2AF2, POLR2B, POLR2E, SAP18, SNRPB2, POLR2G, POLR2I, SMNDC1, DCPS, SF3B1, POLR2K, SPEN, IVNS1ABP, PRPF38A, GPKOW, WTAP, CPSF3, NONO, CPSF2, CDC5L, CWC15, LSM5, SON, ACIN1]
GO:0038110;interleukin-2-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[SYK, IL2RG, JAK3]
GO:0038111;interleukin-7-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;6.832634648514029;0.00101047745553359;0.7003406189322132;[IL2RG, BRWD1, IL7R, JAK3]
GO:0035087;siRNA loading onto RISC involved in RNA interference;8.0;1.0;0.875;9.628524252492122;67.69457493929042;8.390779266560578;0.002265676502055942;0.8041048419030481;[DICER1]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[DUSP22, KLF10, TWSG1, FUT8, COL1A2, BMPR2, PTPRK, ACVR1B, TGFBR1]
GO:0006641;triglyceride metabolic process;7.0;0.8436909121759173;0.7727648213451592;9.318369324188282;85.59385656069774;5.500407508664414;0.0028647493496168257;0.6322104610454062;[CETP, FABP5, GPAM, CAV1, CAT, DDHD2, PCSK9, MGLL]
GO:0003130;BMP signaling pathway involved in heart induction;12.0;1.0;0.9481203125901445;9.628524252492122;313.8403138086527;9.083926447120524;0.010503952865230601;0.9126727335416687;[BMP2]
GO:0045600;positive regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;5.71663061713405;0.00382428925936973;0.6154690682008903;[SFRP1, XBP1, BMP2, SFRP2, ASXL2, SH3PXD2B, STK4, METRNL, STK3]
GO:0048557;embryonic digestive tract morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;31.256231937100466;6.832634648514029;0.0010461179541522844;0.639662265535933;[NIPBL, SHOX2]
GO:0006644;phospholipid metabolic process;5.0;0.5326392268888578;0.5565606253053492;7.595602726447178;99.62941633188608;3.7463883674192062;0.003334506903974791;0.4818314871956144;[ARF3, DPAGT1, SMG1, PIGU, DGKA, CD80, PTEN, PCSK9, DBI, TAZ, PIK3CG, CPNE1, CPNE3, SBF1, FADS1, PDGFRB, PLA2G12A, GGPS1, SPHK2, STARD7, ZFYVE21, VAV1, RUFY1, DPM3, ALDH5A1, IMPAD1, PIGA, KIT, PIK3C3, MET, PAFAH1B1, HBEGF, AGPAT5, VAC14, CETP, GDPD3, PLD1, MTMR6, AGPAT3, MTM1, CLN3, PIP5K1B, CHKB, CHKA, PLEKHA2, AGK, STARD10, DOLK, CRLS1, SYNJ1, FABP5, GPAM, DOLPP1, PEMT, PNPLA6, SERINC3]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[RAB3B, VPS29, AHCYL1, RPL3, NUP107, NCF1, PDCD6, RAB3D, UBE2D3, BCCIP, ZDHHC6, TBC1D3C, IPO7, IPO4, PEX26, RAB43, RPH3A, RPS15, IPO8, IPO9, LAMP2, LONP2, ARFIP1, HOMER3, KPNA4, TBC1D22A, SIL1, VPS18, GSTK1, ARL11, RPS9, RPS7, COG3, AP1B1, TOMM34, TBC1D2B, RPSA, MYO7A, SYTL3, BCR, NUP93, RAB35, ACOT2, CHMP4B, RAB38, RPL29, SLC27A2, KPNB1, ACOT4, RTN2, COPB2, COPA, RAB5C, VPS26A, VPS26B, HSP90B1, NCKIPSD, CLTCL1, VPS11, SSR1, RAB6A, TBC1D17, TBC1D15, VPS16, AP1M1, CTSA, RAB4B, PMM1, RAB3IP, PMM2, ASPSCR1, NUP153, RAB27B, TIMM44, NFKBIA, POLA2, PAN3, NPLOC4, CDK5, BCL3, HYOU1, CD24, ARF3, ARF4, TRAM1, YWHAB, SRP54, CLTA, SEC61A2, AP1G2, AP1G1, NUP62, XPO5, KIF13B, TMED2, TLK1, TMED1, AP3S2, EVI5L, TNPO1, TMED7, TNPO2, ARL5A, TNPO3, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SYK, SSR2, SSR3, TBC1D8, ZDHHC12, RHOB, TBC1D3, ACOX2, AGPS, CAT, EXOC4, SLU7, ARF5, RABGAP1, TOMM40, RAB1B, ZDHHC23, HSD17B4, ZDHHC24, DERL2, PRICKLE1, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, RAB40C, LMNA, AP2S1, HEATR3, STX5, MFN2, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, MBTPS1, CD74, PEX19, RANBP3, AGK, SYVN1, RPL23A, GDAP1, RAB11A, ARCN1, DHRS4, SPCS2, SNX17, NEDD4, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, COPG2, VPS45, SEC24C]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ITGB1, ERRFI1, CD40, DOCK8, DENND1A, ARHGAP1, TBC1D3C, ARHGAP6, DOCK11, PREX1, RGS1, ARHGDIB, EVI5L, TBC1D22A, HRAS, ARHGEF11, SEC13, TBC1D8, TBC1D2B, GMIP, VAV1, ARFGAP1, BCR, TIAM2, DEPDC1B, SFRP1, TBC1D3, ALS2, TBC1D20, CDC42EP4, DEPDC1, RAPGEF1, PKP4, TAX1BP3, ARHGEF1, RIN3, DOCK2, EPHA1, ARHGEF5, RABGAP1, RGS19, CCL3L1, RASGRP2, RASGRP3, RIC8A, ABR, ARHGAP21, RIC8B, CCL5, CCL3, DVL3, CCL2, NCKAP1L, CCL19, ECT2, A2M, TBC1D17, TBC1D15, S100A10, STARD13, RANBP3, SEMA4D, CCL20, RCC2, MYO9B, ARHGAP26, ARHGAP25, ARHGAP30, GNAQ, DLC1, RUNDC1, RAB3GAP2, SMAP1, RAB3GAP1, EZH2, LIMS1, PICALM]
GO:0050873;brown fat cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;6.444869117505266;7.282666309192915E-4;0.6198319182472036;[LAMB3, ZNF516, METRNL]
GO:0032801;receptor catabolic process;6.0;0.8436909121759173;0.7449657686781032;9.34084218004034;102.12013474586499;6.518977089658987;0.003417869007789623;0.6565011041187423;[BECN1, MYLIP, CDK5, SNX25, NEDD4, AP2S1, CLTA, PCSK9, CAPN1]
GO:0032802;low-density lipoprotein particle receptor catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;464.4154505485325;7.474488534686424;0.01554356718308929;0.7331650565203278;[MYLIP, AP2S1, CLTA, PCSK9]
GO:0051047;positive regulation of secretion;6.0;0.5250478409461853;0.5856442330632372;7.054005444014434;46.28499923684045;3.8109268885567773;0.00154911727066213;0.5180112908971621;[GPI, OXTR, RAB3D, ITGB2, PTPN22, TM7SF3, AACS, AQP1, AP1G1, HYAL2, NPPA, RAB8B, HAVCR2, FGA, PDCD6IP, IL4R, FCER1G, SYK, PRKCE, FGG, ACSL3, UNC13D, VAMP8, GAL, KARS, ADORA2A, TLR8, GAPDH, PPID, EXOC1, PTGER4, VPS4B, NLRP7, NLRP2, ABL1, CCL3, NLRP3, MBP, CCL19, CLASP1, NTSR1, ATG5, PCK2, TCF7L2, XBP1, CADM1, GLMN, RAB27B, BAIAP3, P2RX7, NLRP12, IL6, P2RX4, CDK5, SDC1, CD244, RAB3GAP1]
GO:0070244;negative regulation of thymocyte apoptotic process;11.0;1.0;0.9324289523296623;9.628524252492122;182.70429597134583;7.697632086000634;0.006114948362969828;0.8260862151842345;[JAK3]
GO:0071333;cellular response to glucose stimulus;8.0;1.0;0.875;9.628524252492122;272.3004295980195;5.69953618377475;0.009113650324169357;0.6664745454937787;[ERN1, XBP1, ENDOG, SIN3A, SERPINF1, GJB6, AACS, NME1, PCK2]
GO:0032805;positive regulation of low-density lipoprotein particle receptor catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;1379.6895391718747;9.083926447120524;0.046176967236111484;0.8607930461318132;[PCSK9]
GO:0051042;negative regulation of calcium-independent cell-cell adhesion;7.0;1.0;0.8509193652572005;9.628524252492122;69.05345888857988;9.777073627680469;0.002311157124922504;0.8509193652572005;[BMP2]
GO:0032927;positive regulation of activin receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;235.39356054473234;7.697632086000634;0.007878410630981547;0.7686572628545723;[ACVR1B]
GO:2001247;positive regulation of phosphatidylcholine biosynthetic process;10.0;0.8933024483968273;0.861892236059334;9.56398573135455;851.1005460523235;9.777073627680469;0.028485569335608904;0.9152410118609203;[ACSL3]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[BECN1, ZNF175, CD40, CXCL9, DDX41, ZC3HAV1, SAMHD1, LYST, RELA, HYAL2, NLRP3, IFNAR2, DDX17, APOBEC3F, DTX3L, APOBEC3H, MX2, TMEM173, UNC13D, ITCH, ILF3, IL6, CNOT7, GPAM, POLR3B, POLR3C, IL23A, POLR3E, DDIT4, TLR8, TLR7, SERINC3, APOBEC3A, EXOC1]
GO:0031397;negative regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;529.4632463014641;5.572381008289503;0.01772065836772442;0.7002128357670632;[IVNS1ABP, DTX3L, RPS7, CAV1, PRKCE, GLMN, PRMT3, GPS2, PARK7, SENP2, PER2, GNL3L, CDK5, U2AF2, UBR5, ABL1, FBXO5, MAD2L1, ATG5]
GO:0016575;histone deacetylation;9.0;0.7866048967936545;0.7895430735771163;9.396722638434797;357.60632662761185;5.682729065458369;0.011968761927426838;0.6868556538617572;[HDAC3, HDAC1, PRDM5, ARID4A, SIRT7, SIRT2, PER2, BRMS1, TBL1XR1, SIN3A, SAP18, SUDS3, RBBP7, MTA2]
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway;9.0;0.7436939687323844;0.7680876095464813;9.413412872875176;597.3701724921605;5.233778845410465;0.0199934420750612;0.663896318730187;[CDKN2D, IVNS1ABP, CD74, XBP1, WFS1, NONO, SYVN1, PLAUR, PARK7, BCL2L12, CREB3, ING2, HSPH1, SFRP2, PPIF, VDAC2, HYOU1, BID, TRIM32]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[TFAP2A, P2RX7, BMP2, BMPR2, TMEM119, FAM20C]
GO:1905596;negative regulation of low-density lipoprotein particle receptor binding;7.0;1.0;0.8509193652572005;9.628524252492122;65.6888655603143;9.777073627680469;0.00219854721416286;0.8509193652572005;[PCSK9]
GO:0033690;positive regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.379178354882098;0.0021103132289136558;0.7004918368257019;[BMP2, ABL1, TMEM119, SOX8, ITGAV]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[CMTM7, ITGB1, CR2, DCLRE1C, CEBPG, GPS2, DOCK11, KLF6, SP3, BCL3, KIT, ABL1, EP300, JAK3, CARD11]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[CXCL6, OXTR, CXCL9, AHCYL1, DGKD, DGKA, DEFB1, PIK3CG, HEBP1, AKAP13, PREX1, GPR132, GNAT2, RGS1, ADORA3, NPPA, OR56B1, HOMER3, PDE8A, CCR2, PDGFRB, ARHGEF11, CD97, ANXA1, SPHK2, SPHK1, AGTRAP, RHOC, ADRA2C, VAV1, VAV2, RHOB, TIAM2, SFRP1, GAL, SFRP2, ADORA2A, SPNS1, ARHGEF1, DAGLB, GPRC5D, ARHGEF5, XPR1, ATF4, PTGER4, SUCNR1, RGS19, CCL3L1, ROCK2, ADCY4, IQGAP2, CRHR1, RIC8A, C3, P2RY8, ABR, GNG2, RIC8B, TBXA2R, HRH2, CCL5, GRK6, CCL3, GNG8, CCL2, CCL19, ECT2, NTSR1, CCR10, SULT1A3, SLC12A2, CCL20, CAV1, GPR55, FZD6, TSHR, BAIAP3, POMC, CXCL11, GPR180, GNAQ, GNB2, PNOC, NMUR1, CALM3, PTPN6, CALM1, CALM2]
GO:0030182;neuron differentiation;4.0;0.5833093054345528;0.5416546527172764;7.212610474191073;21.066225782797595;4.296434704338478;7.050676185779127E-4;0.4697198705845162;[MTPN, PIGT, RYK, ROM1, PAPD4, PCSK9, RORA, RUNX2, RUNX1, NR4A2, PPP1CC, SFRP1, HERC1, CDK5, CASP3, DDIT4, XRN2, SOX8, ATP7A, IER2, PAFAH1B1, ATF4]
GO:1905598;negative regulation of low-density lipoprotein receptor activity;9.0;1.0;0.896240625180289;9.628524252492122;185.81802110222043;9.777073627680469;0.006219161940929516;0.896240625180289;[PCSK9]
GO:0035196;production of miRNAs involved in gene silencing by miRNA;10.0;1.0;0.9152410118609203;9.628524252492122;119.55896959962375;7.069023426578259;0.004001531116412497;0.7767511986393403;[ZC3H7A, SNIP1, DICER1, PUM2]
GO:0032482;Rab protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;5.500407508664414;9.9090025448413E-4;0.6562910957882058;[RAB3B, RAB5C, RAB4B, RAB3D, RAB1B, RAB27B, RAB11A, RAB21, RAB43, RAB20, RAB40C, RAB13, RAB35, RAB18, RAB38, RAB28, RAB6A, RAB8B]
GO:2000172;regulation of branching morphogenesis of a nerve;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;59.274657408465146;8.390779266560578;0.0019838694397330287;0.7522251544931926;[SHOX2]
GO:0060317;cardiac epithelial to mesenchymal transition;6.0;0.7980440201809971;0.722142322680643;9.0094850440859;24.75510523691153;6.481236761676141;8.285310941311355E-4;0.6545710619905948;[OLFM1, BMP2, SPRY1, TGFBR1]
GO:0045732;positive regulation of protein catabolic process;7.0;0.7043150770688792;0.7030769037916401;9.033817144745429;231.0521549826792;4.39257856489138;0.0077331076938309705;0.5755560373415389;[USP13, ZFAND2A, PTEN, PCSK9, PRICKLE1, FZR1, GGA3, RNF138, VPS11, UBQLN1, STX5, LONRF3, DACT1, MYLIP, XBP1, EGLN2, CSNK2A1, EDEM1, CAV1, ATPIF1, MSN, RAD23A, SIRT2, RNF40, DDB1, ITCH, PSMC1, NEDD4, TRIB3, TRIM32, RNF166]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, PYGB, GPI, SIGLEC9, FRMPD3, RAB3D, CRISP3, ITGB2, HK3, PSMD7, ACTR1B, FCGR3B, PLAU, PSMD2, LAMP2, CPNE1, TIMP2, CTSH, ITGAV, CPNE3, CAPN1, GUSB, SNAP29, CAP1, CD97, ACTR2, SERPINB1, HLA-H, FCER1G, DBNL, CR1, MME, PRKCD, PLAUR, COMMD3, RNASE3, TMEM173, SCAMP1, UNC13D, SERPINB6, VAMP8, ACLY, CAT, TMBIM1, ALDOC, DOCK2, ALDOA, ACPP, SLC27A2, KPNB1, CSTB, PDXK, RAB5C, CLEC12A, UBR4, IQGAP2, PLD1, C3, RAP1B, COMMD9, CYB5R3, ALDH3B1, PSMB1, NCKAP1L, RAB6A, ARSB, AP1M1, CTSA, XRCC6, MGAM, TMEM30A, RAB4B, GSN, JUP, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, VAPA, IMPDH1, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1, PTPN6]
GO:0002053;positive regulation of mesenchymal cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;64.15119587261817;6.444869117505266;0.002147082793528545;0.6527112189764278;[TBX1, MYC, SHOX2]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[TFRC, CD80, EBI3, CORO1A, AGER, HLA-DMB, CCL5, NCKAP1L, IL12A, CCL19, IL12RB1, JAK3, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, PDCD1LG2, CCDC88B, CD4, IL6, GPAM, IL23A, HLA-DPB1, CD24, CARD11]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[ITGB1, SCARB1, DGKD, TFRC, SH3KBP1, NCF2, WIPF2, ITGB3, DENND1A, ITGB2, STON1, LY75, CLTA, UBE3A, WASL, FNBP1L, RABEPK, PIK3CG, KIAA1109, ANKFY1, ITGAV, SCARF1, HRAS, CAP1, FCER1G, DBNL, ANXA1, SYK, FNBP1, UNC13D, NME1, DNM2, RUFY1, GAK, ADORA2A, RARA, PIK3C3, RIN3, AMPH, RHOU, DOCK2, MET, CSNK1G2, CSNK1G1, C9orf72, COLEC12, CD163L1, CEBPE, WAS, LRP8, CORO1A, AGER, TM9SF4, HSP90B1, CLN3, HSPH1, CLTCL1, AP2S1, APOL1, ATP9A, AMBP, CAV1, CDC7, MARCH3, MIB1, EHD4, SYNJ1, CDK5, SNX17, NEDD4, CD9, HYOU1, FOLR2, PICALM]
GO:0046824;positive regulation of nucleocytoplasmic transport;7.0;0.7586651285174919;0.7302519295159464;9.136047767394327;95.6931674171318;5.572381008289503;0.003202764195191997;0.6358911891633434;[TCF7L2, HDAC3, CPSF6, JUP, PRKCD, TMEM173, BAG3, HYAL2, NEDD4, TPR, UBR5, CAMK1, ECT2, GTSE1, EMD]
GO:0000422;autophagy of mitochondrion;6.0;0.8653626801206646;0.7558016526504768;9.446202695698167;99.5332381578633;6.015873511986907;0.003331287907044985;0.6307723637598831;[BECN1, GABARAPL1, FUNDC1, CTSK, MARK2, ATG5, ATG2B]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[DCTN6, DCTN5, COPB2, ARF4, COPA, DCTN2, DCTN4, PDCD6, RAB1B, GOSR1, DCTN3, KLHL12, TEX261, MIA3, RAB43, ACTR1A, SPAST, TFG, CAPZB, TMED2, STX5, TMED1, TMED7, TMED4, TRAPPC2, TRAPPC3, TMED9, TRAPPC2L, COG5, COG4, COG3, DDHD2, COG1, DYNLL2, SPTB, ARFGAP1, YIF1A, ARCN1, TBC1D20, TMEM115, VAPA, TRAPPC6B, GOLGB1, COL7A1, HYOU1, COPG2, SEC24C, SEC22C]
GO:0051056;regulation of small GTPase mediated signal transduction;7.0;0.6799073451904818;0.6908730378524415;8.647694999480395;45.070113835906206;4.018171853803189;0.001508456149618737;0.5564088607247961;[ITGB1, DENND1A, KIF14, ARHGAP1, ARHGAP6, FLCN, AKAP13, PREX1, RASGEF1A, PSD4, NUP62, ARHGDIB, TIMP2, HRAS, PDGFRB, ARHGEF11, RHOC, GMIP, VAV1, VAV2, RHOB, DNM2, BCR, ITPKB, TIAM2, DEPDC1B, ALS2, MADD, RAPGEF1, ARHGEF1, RHOU, MET, ARHGEF5, RASGRP4, P2RY8, ABR, ARHGAP21, RHOT2, RHOT1, ABL1, MFN2, ECT2, A2M, ARFGEF2, STARD13, GPR55, MYO9B, ARHGAP26, ARHGAP25, ARHGAP30, DLC1, KRAS, SPRY1]
GO:0042471;ear morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;47.43365404998557;8.390779266560578;0.0015875617135358803;0.7193458537639684;[TBX1, NIPBL, GJB6]
GO:0001516;prostaglandin biosynthetic process;11.0;0.8933024483968273;0.8790801765280758;9.597752593825367;1037.183190875448;7.138016298065211;0.03471358799433119;0.7974674377644215;[CD74, PTGES]
GO:2000726;negative regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;669.6541776470041;7.292166977892469;0.022412722676212672;0.769162383550154;[G6PD, BMP2, SOX6]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[PDGFRB, OXTR, ENDOG, PCNA, ANXA1, ITGA2, ABCB4, LOC400499, PTEN, WFDC1, CD4, SFRP1, CASP8, CASP3, CAT, RARA, PAM, EZH2]
GO:0035987;endodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;6.444869117505266;7.050676185779127E-4;0.5795909063862833;[LAMB3, COL7A1, ITGB2, ITGAV, MIXL1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[ITGB1, ERRFI1, CXCL6, GPI, CXCL9, GMFB, NCF1, PTEN, SECTM1, PCSK9, IL27, PARK7, METRNL, CXCL14, BICD1, PLAU, NPPA, IL12A, FAM3C, CAPN1, TIMP1, BUD31, PRKCE, PRKCD, FLT3LG, ADRA2C, GAL, SFRP2, IL23A, CHMP6, HBEGF, COPA, CCL3L1, EBI3, CLEC12B, AGER, CCL5, CCL3, CCL2, CCL19, CMTM7, UBE2I, TNFSF14, CCL20, CD70, BDNF, GDF1, NETO2, KLHL24, POMC, IL6, CXCL11, BMP2, CDK5, PNOC, SCGB3A1, KCNK3]
GO:0010586;miRNA metabolic process;8.0;0.8653626801206646;0.8076813400603323;9.456673995565463;117.72069011476309;6.943860283624253;0.003940005556398338;0.7301093378270707;[DDX17, XPO5, DICER1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[CCNF, UBE2D3, UBE3A, UBE2Z, UBE2L3, NPEPPS, HERC4, HERC1, CDC26, TRIM24, TRIM27, SKP2, C18orf25, ATXN7L3, MYLIP, RNF44, FBXO18, ARRDC1, FBXW11, UBE2E3, UBE4A, TRPC4AP, RC3H2, RNF40, KCTD10, ANAPC5, CBLL1, NAIP, HIST1H2BC, RNF121, ANAPC13, CDCA3, KLHL14, MYCBP2, UBR4, DTX2, KLHL12, FBXO41, ANAPC11, VCPIP1, RNF213, MED30, UBD, HLTF, UBR5, RNF170, LONRF3, WDTC1, UBE2I, UBE2B, KLHL25, FANCL, LNPEP, KLHL24, MARCH6, MARCH3, CNOT4, RNF103, KLHDC8A, UBE2T, CDC16, FBXL3, PPP1R11, BRCA1, MED12, TRIM9, TRIM7, TRIM69, DTX3L, ZFP91, PJA2, DDB1, MED20, BIRC6, THOP1, RNF166, BIRC3, HIST1H2BO, PCNA, HIST1H2BJ, MGRN1, RNF38, NEDD8, NLRC4, RNF135, FZR1, ZNRF2, RMND5A, RAB40C, RNF138, RFFL, SASH1, RNF20, FEM1B, SYVN1, FBXL15, FBXL16, MIB1, ITCH, SPSB1, RFWD3, ASB8, NEDD4, TSPAN17, KBTBD2, ASB7, TRIM32, ASB3, KBTBD8, TRIM33]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[ITGB1, VPS18, SCARB1, GYPA, CR2, CR1, TFRC, SIVA1, ITGB3, ITGA2, CD80, NUP153, RPSA, VAMP8, ITCH, CLDN9, HYAL2, NCAM1, ITGAV, XPR1]
GO:0044539;long-chain fatty acid import;11.0;1.0;0.9324289523296623;9.628524252492122;75.02792930111643;7.474488534686424;0.0025111172729558144;0.8146746435927894;[ACSL3, SLC27A2]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[WDR1, EPB41, SH3KBP1, WIPF2, LST1, ITGB2, WAS, WASL, CORO1A, CCL3, CCL2, TBCCD1, ANXA1, SEMA4D, MSN, CDC7, VRK1, VRK2, RHOC, RHOB, VIL1, MKLN1, CFDP1, FES, CDC42EP4, DLC1, TAOK2, KIT, MYH9, RHOU, ALDOA, BRWD1, CSNK1G2, CSNK1G1]
GO:2000065;negative regulation of cortisol biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;1464.246860894009;8.390779266560578;0.04900702469750238;0.8615337942327104;[BMP2]
GO:0043200;response to amino acid;5.0;0.6441938053840475;0.612337914552944;8.412128928167629;56.712201515420396;5.104244793218563;0.0018981063470534028;0.5512723279577749;[XBP1, PCNA, ABCB4, CRLS1, RELA, COL1A2, CASP3, CFL1, CAPN2, PEMT, PIK3C3, ATP7A, NAIP, CPEB4]
GO:1902895;positive regulation of pri-miRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1721.2385553242598;6.599019797332524;0.0576083054325737;0.7855944919115336;[BMP2, RELA, GNL3]
GO:0006622;protein targeting to lysosome;11.0;0.9326813400603323;0.8987696223598284;9.592156608321247;250.3799473132135;6.781341354126479;0.008379991509250163;0.7792270645443136;[AP3M1, NEDD4, LAMP2]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[PRKCSH, SERPINA10, CCNF, PCSK9, MIA3, LAMC1, MSLN, PSMD8, ANKRD9, PSMD7, PSMD4, PSMD2, TIMP1, SKP2, FGA, IGFBP5, ESCO1, FBXW11, FGG, COMMD1, RABGGTA, SUMF2, SUMF1, DDB1, PSMA1, PSME2, FAM20C, RAB38, ITIH2, GPS1, RAB1B, COPS7B, NEDD8, COPS7A, PSMB10, PSMA7, FBXO41, HSP90B1, C3, TGOLN2, PSMB5, RBBP5, UBD, PSMB1, RBBP7, APOL1, ATG5, WDTC1, MBTPS1, KLHL25, WFS1, FEM1B, RHBDD1, FBXL15, FBXL16, BTBD6, RAB11A, IL6, SPSB1, COPS5, PSMC1, ASB8, RAB13, STT3A, CALU, ASB7, FBXL3, ASB3, KBTBD8]
GO:0045626;negative regulation of T-helper 1 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2656.54802066489;8.67846133901236;0.08891227151365512;0.9063718812344532;[IL4R, JAK3]
GO:0043569;negative regulation of insulin-like growth factor receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;187.41437209568753;7.9853141584524145;0.006272590372058239;0.7592887026755414;[BMP2, IGFBP5]
GO:1900119;positive regulation of execution phase of apoptosis;8.0;0.8436909121759173;0.7968454560879586;9.420884887713877;104.73281067498594;7.292166977892469;0.0035053129198816214;0.747921758369865;[ENDOG, FAP, DLC1, TP53BP2, BAX, SIRT2]
GO:0070383;DNA cytosine deamination;9.0;1.0;0.896240625180289;9.628524252492122;166.36310735944548;7.57984905034425;0.005568023486244473;0.7838744581139225;[APOBEC3F, CDADC1, APOBEC3H, APOBEC3A]
GO:0050772;positive regulation of axonogenesis;10.0;0.7436939687323844;0.7870879962271125;9.36383169826504;884.0118179988558;5.395046993006588;0.02958707998943757;0.6911439659786198;[BMPR2, SEMA4D, TNFRSF12A, BDNF, RUFY3, SHOX2, TWF2, ADNP, TRAK1, MEGF8, RAB11A, PAFAH1B1]
GO:0045078;positive regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.212124270218933;0.027942676825076673;0.7438283705770736;[EBI3, CEBPG, TLR8, IL27, TLR7]
GO:0050770;regulation of axonogenesis;9.0;0.6324783794010864;0.7124798148808322;8.859391164954255;152.1280667645758;4.606589632642318;0.005091589488238978;0.6318218332219429;[BMPR2, SEMA3C, SHOX2, TWF2, PTEN, TRAK1, RAB21, KIF13B, ABL1, MARK2, SEMA6B, SEMA4D, TNFRSF12A, BDNF, SEMA4B, OMG, SSH3, RAB11A, SSH1, DNM2, OLFM1, CDK5, RUFY3, ADNP, MEGF8, PAFAH1B1]
GO:0042482;positive regulation of odontogenesis;7.0;0.8436909121759173;0.7727648213451592;9.474373572664863;103.86878039186215;7.379178354882098;0.0034763946038822383;0.728290889492758;[TFAP2A, BMP2]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[ITGB1, PRIM2, CDKN1A, USP37, MAX, GMNN, MCM10, ACVR1B, PPP6C, GPR132, PPAT, MYC, SKP2, CDKN2D, CDKN2C, RANBP3, CDC7, CDC25A, POLE4, WEE1, POLA2, CDK6, CCNE2, CCNE1, POLE2, CDK2, POLE3, MCM5, RHOU, MCM6, MNAT1, MCM2]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[ABCC2, CCL3L1, CCL20, CIB1, RORA, BRCA1, THBS1, TANK, NFKB1, RELA, SFRP1, BAG4, CCL5, HYAL2, CCL3, CCL2, RIPK1, CCL19, MAP3K5, PCK2]
GO:0032348;negative regulation of aldosterone biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;1299.8819356928807;8.390779266560578;0.043505878569849596;0.8443458537639685;[BMP2]
GO:0042921;glucocorticoid receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;54.70458253798286;7.8311634786251565;0.0018309131466183446;0.7967266896635242;[NCOA6, NEDD4, ARID1A]
GO:0007043;cell-cell junction assembly;5.0;0.7508913569872202;0.6656866903545304;8.817594036275793;53.94372379865016;5.16195311083921;0.0018054478893412883;0.554223534004606;[PDCD6IP, WDR1, JUP, ARL2, RHOC, MTDH, UGT8, FLCN, RAB13, CD9, PKP4, PKN2, TLN2, ECT2, TLN1]
GO:0030041;actin filament polymerization;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;66.55674193746657;6.409777797693995;0.0022275942554681166;0.6787156999164222;[VIL1, PREX1, GSN, ARPC2, WAS, ARHGAP6, TTC17]
GO:1900005;positive regulation of serine-type endopeptidase activity;11.0;1.0;0.9324289523296623;9.628524252492122;1124.6226316613872;8.67846133901236;0.037640107387048885;0.8762458687964789;[CR1]
GO:0007167;enzyme linked receptor protein signaling pathway;6.0;0.5334320500414464;0.5898363376108677;7.041834908394179;26.50247477320489;3.253511321530957;8.87013979980389E-4;0.48950503287698693;[CYFIP2, NCKAP1, ARF4, DGKD, BMPR2, NCF1, NCF2, ITGB3, PDCD6, ARPC1A, UBE2D3, PTEN, WASL, PTPRK, IGF1R, TIAL1, PTBP1, RPS6KA5, RASSF2, CASP3, NPPA, ITGAV, CPNE3, HRAS, JAK3, EPHB4, APPL1, PDGFRB, KLF10, ACTR2, CAMLG, SYK, GFRA2, RUNX2, SIRT2, VAV1, TGFBR1, VAV2, BCR, DUSP22, TWSG1, DOK2, SLC9A6, CD8B, DDIT4, KIT, ELMO1, RAPGEF1, LCP2, EPHA1, MET, HBEGF, ROCK2, NEDD9, ACVR1B, EFNA4, AKAP2, RASGRP4, SGPL1, FUT8, POLR2B, AP2S1, ATP6V0A2, ABL1, POLR2E, POLR2G, NCKAP1L, CSK, POLR2I, SH2B2, POLR2K, PAG1, ATP6V1F, FAM83A, ANGPT1, BDNF, EIF2AK3, GDF1, PILRB, PILRA, SHCBP1, SETX, VIL1, CD4, BMP2, COL1A2, ARPC2, PTPRA, FES, TEK, MEGF8]
GO:1900004;negative regulation of serine-type endopeptidase activity;11.0;1.0;0.9324289523296623;9.628524252492122;1126.6123068633772;7.379178354882098;0.03770670002546806;0.8098004765652196;[CR1]
GO:0042487;regulation of odontogenesis of dentin-containing tooth;7.0;0.811012628672052;0.7564256795932265;9.34084218004034;47.77839987207684;7.138016298065211;0.0015991000459501783;0.7159578506919597;[BMP2, RUNX2]
GO:0048468;cell development;3.0;0.5052934683962566;0.45076704678827284;6.510574346213882;28.41553699003407;3.2909128387363804;9.510424507334451E-4;0.36641774820622075;[BTG2, BMPR2, ONECUT2, MAML1, PDCD6, ARID4A, CIB1, MSI2, AFF4, GBA2, TIAL1, MED12, ING2, GNAT2, EP300, SOX8, HORMAD1, ATP7A, SOX6, STRBP, SECISBP2, THOC2, BPGM, MYO7A, IQCG, RUNX2, RUNX1, NUP93, BIN3, SFRP2, IMPAD1, KIT, RAPGEF1, MYADM, RARA, PAFAH1B1, BECN1, ABCB4, SHOX2, NOLC1, KLHL12, AGER, FXR1, RAP1B, CCNB1, LMNA, NCKAP1L, TSPAN2, ATG5, EIF2B4, XBP1, GSN, PTCD2, SPAG6, NEBL, ODF2, H3F3A, PBX3, EIF2AK3, MSN, GDF1, FLI1, BMP2, CDK6, CDK5, UQCRQ, GNAQ, RAB13, SDC1, CD9, BAX, CCM2, KRAS, PTPN6, KBTBD8, TJP2]
GO:0006633;fatty acid biosynthetic process;8.0;0.6493065804076676;0.6996532902038338;8.912904216080118;359.8485513982277;5.076593261888053;0.01204380717262807;0.6346172154986847;[CD74, XBP1, ACOT7, ABCD3, ACSM3, ELOVL5, ELOVL6, BRCA1, ACSL3, LIAS, HSD17B8, PRKAB1, MCAT, ACACA, FADS3, ACLY, DEGS1, FADS1, MGLL, PTGES]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[PTGER4, OXTR, STOML2, CD40, CAMK2D, CXCL9, ITPR2, ATP2A2, ATP2C2, PKD2, PIK3CG, P2RY8, CLN3, GNAT2, TBXA2R, CCL5, ABL1, CDH23, CCL3, PDE6B, ITGAV, CCL19, NTSR1, CCR10, GTF2I, CCR2, ATP13A1, WFS1, CAV1, SWAP70, PRKCE, GPR55, ATP2B4, P2RX7, CD4, P2RX5, CXCL11, P2RX4, BAX, CALM3, ATP13A3, CALM1, CD24, CALM2, KCNK3, PVALB]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, TCF7L2, HDAC1, CAV1, CHD8, FZD6, KLHL12, PRICKLE1, STK4, STK3, AES, CYLD, SFRP1, BMP2, SFRP2, RAPGEF1, DVL3, EMD, DACT1]
GO:0019371;cyclooxygenase pathway;10.0;1.0;0.9152410118609203;9.628524252492122;253.27491700286936;7.379178354882098;0.008476883539459374;0.7926125360964777;[PTGES]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[NCF1, NCF2, CRISP3, DEFB1, IL27, LYST, IPO7, PIK3CG, PPP6C, C1QBP, TRIM27, JAK3, HAVCR2, MAP3K5, FGA, MAP4K2, CR2, FCER1G, ANXA1, CR1, DTX3L, SYK, WRNIP1, RNASE3, IRAK4, TMEM173, SIRT2, IL23A, ELF4, PSPC1, TRIM14, TLR8, TLR7, TLR10, CFB, NAIP, HIST1H2BC, ANKRD17, COLEC12, HIST1H2BJ, CFH, CEBPG, NLRC4, ZC3HAV1, LILRA2, CORO1A, AGER, RELA, C2, C3, RNF135, CLEC7A, PRDX1, NLRP2, ABL1, SLAMF7, NLRP3, CSK, APOL1, XRCC6, PPP1R14B, APOBEC3F, APOBEC3H, XRCC5, NONO, MX2, NFKB1, ANKHD1, CYLD, ITCH, POLR3B, POLR3C, FES, TREML4, POLR3E, PTX3, PTPN6, SERINC3, TRIM32, CD244, APOBEC3A, C1QC]
GO:0006749;glutathione metabolic process;6.0;0.8436909121759173;0.7449657686781032;9.360260265897443;147.28945980206763;5.71663061713405;0.0049296456676673804;0.6154690682008903;[GSTK1, G6PD, GSTO2, CTNS, PARK7, GDAP1, CNDP2, SOD1, GSTA5, ALDH5A1, CHAC2, MMACHC, PTGES]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[CCL3L1, PTEN, CIB1, PTPN22, AGER, IGF1R, RAP1B, CCL5, ABL1, CCL3, CCL2, CCL19, HRAS, PDE8A, EPHB4, HAVCR2, PDGFRB, FGA, CD74, ANGPT1, CCL20, RYK, FGG, GPR55, CD4, BMP2, KARS, KIT, RAPGEF1, TEK, EPHA1, MET]
GO:0045880;positive regulation of smoothened signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;187.6437959822434;6.343086423195323;0.006280268983073171;0.6753050999230941;[SFRP1, SHOX2, TUBD1, GAS8]
GO:0035723;interleukin-15-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.212124270218933;0.00101047745553359;0.7197477358342742;[IL15RA, CD4, IL2RG, JAK3]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[UPF1, CD40, ABCC2, CCL3L1, CCL20, FGG, RORA, TANK, NFKB1, RELA, MAPK13, YY1, SFRP1, NLRP7, CCL5, HYAL2, CCL3, CCL2, CCL19]
GO:0016540;protein autoprocessing;7.0;1.0;0.8509193652572005;9.628524252492122;102.5832240862455;7.138016298065211;0.00343336819125881;0.7159578506919597;[CAPN2, PCSK9, CTSE]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[ACTR2, GSN, CCL3L1, CCL20, WAS, VPS26B, RAB43, RAB20, CCL5, CDC42EP4, CCL3, CCL2, CCL19, IL12RB1, GAPDH, HLA-DPA1]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[C1QBP, TLR8, THBS1, JAK3, NFKB1]
GO:0030036;actin cytoskeleton organization;5.0;0.6347111282356054;0.607596575978723;8.048073876931273;29.6146440060229;3.9779809732199434;9.911754834323397E-4;0.49367514382642164;[ITGB1, NCKAP1, RTKN, WDR1, WIPF2, ARPC1A, TESK2, WASL, AQP1, CAPZB, CFL1, PDGFRB, ARHGEF11, MYLIP, PDCD6IP, ANXA1, KIF23, RHOC, RHOB, BCR, NISCH, TNNT1, KIT, SPECC1L, ELMO1, MYH9, RHOU, DOCK2, TLN1, ARHGEF5, PAFAH1B1, EPB41, ROCK2, WAS, CORO1A, ABR, ABL1, NCKAP1L, ARHGAP26, CORO2A, SSH1, VIL1, MKLN1, DIAPH3, PARVG, CDK5, DLC1, RAB13, TAOK2, KRAS, TRIM32]
GO:0061179;negative regulation of insulin secretion involved in cellular response to glucose stimulus;11.0;1.0;0.9324289523296623;9.628524252492122;1298.6518127055795;7.57984905034425;0.04346470746050344;0.8200627852632958;[PIM3]
GO:0032290;peripheral nervous system myelin formation;6.0;1.0;0.8231203125901445;9.628524252492122;33.54444455821997;9.083926447120524;0.0011227023713234936;0.7876727335416686;[DICER1]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[PDGFRB, BECN1, NCF1, ANGPT1, SEMA4D, CCL5, NEDD4, KIT, CAT, UBE3A, PTPN6, TEK]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[P2RX7, NLRP12, NLRP7, NLRP2, CCL3, NLRP3, TLR8, CCL19]
GO:0022008;neurogenesis;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.572381008289503;7.050676185779127E-4;0.5349718239061428;[CDK6, ANXA1, RYK, BCL11A, PCSK9, THOC2, BTBD6, TRAK1, DAGLB, CIT]
GO:1990001;inhibition of cysteine-type endopeptidase activity involved in apoptotic process;13.0;1.0;0.9625549647676366;9.628524252492122;2010.8653136723324;7.292166977892469;0.06730185238732382;0.8354767231375014;[BCL2L12, BIRC6, NLRC4, UBE2Z, NAIP, BIRC3]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[MAP3K1, TNIP1, TLR8, TLR7, TLR10, IRAK4]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[BECN1, SUV39H1, ABCB4, PTEN, PSEN2, ITPR2, RORA, THBS1, AQP3, AGER, TM9SF4, HSP90B1, AQP1, NPEPPS, ALKBH5, CCNB1, PLAU, MYC, FUNDC1, CASP3, UCP3, NPPA, LMNA, UBQLN1, CAPN2, EP300, SCAP, ATP7A, CREBBP, EGLN2, ENDOG, ITGA2, CAV1, PRKCE, ARNT, AGTRAP, SIRT2, NR4A2, SFRP1, BMP2, TBL2, DDIT4, CAT, HYOU1, TEK, CD24, PAM, KCNK3]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDKN1A, BMPR2, BTG1, SEMA3C, EI24, WFDC1, ACVR1B, ADIPOR2, PPP2CA, FLCN, SERTAD3, SERTAD2, HYAL2, NPPA, RBBP7, SEMA6B, CDKN2D, G6PD, CDKN2C, SEMA4D, SEMA4B, EAF2, SFRP1, GAL, SFRP2, CDK5, SCGB3A1]
GO:0071773;cellular response to BMP stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.280566066213989;0.003262744749111514;0.6443087532925187;[SFRP1, BMP2, BMPR2, RUNX2]
GO:0019089;transmission of virus;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;31.98153817412437;9.777073627680469;0.0010703933011722401;0.7902410118609202;[NEDD4]
GO:0030422;production of siRNA involved in RNA interference;10.0;0.9326813400603323;0.8815816818910864;9.574457031221845;119.55896959962375;7.697632086000634;0.004001531116412497;0.8088982747154926;[DICER1]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[NCKAP1, OXTR, TESK2, CALML4, RPS6KA4, PREX1, RPS6KA5, RPS6KA2, MYC, ARL6IP5, GTSE1, PDK1, PRKCE, PAQR3, PRKCD, BCR, NISCH, TIAM2, DEPDC1B, KARS, DDIT4, TRIB3, ATF4, PAXIP1, CRHR1, ABR, NUAK1, RHOT2, RHOT1, PPP4C, RRAS, TP53BP2, STK38L, CCR10, SULT1A3, PAG1, XBP1, SETDB1, EIF2AK3, RAB27B, SETX, CCDC88A, CYLD, COL1A2, CALM3, CALM1, RGL1, CD24, CALM2, BTG2, CDKN1A, CD40, ARHGAP1, BRCA1, ARHGAP6, BBC3, AKAP13, AKAP11, NKIRAS1, C1QBP, CTSH, HRAS, JAK3, TEAD2, RAB8B, CCR2, DUSP5, MAP4K2, DBNL, RIPK3, SPHK1, TMEM173, RHOC, GMIP, GFRA2, SIRT2, VAV1, CIT, VAV2, RHOB, ITPKB, GAL, CDC42EP4, KIT, DEPDC1, RAPGEF1, TLR8, TAX1BP3, ARHGEF1, TLR7, RHOU, ARHGEF5, EXOC1, HBEGF, PTGER4, PCNA, GPS1, ADCY4, WAS, GPS2, TANK, RELA, PPP2CA, PERP, BID, MAP3K3, MAP3K1, GSN, CCL20, MYO9B, RAB11A, ITCH, CAMK4, TAOK2, PKN2, CAMK1, TJP2, RAB3B, DGKD, RTKN, DGKA, CD80, RAB3D, SIRPG, IL5RA, DEFB1, PARK7, IGF1R, RAB43, DOCK11, ARHGDIB, CFL1, EP300, SNIP1, NEK1, MAP3K5, IFNAR2, PDGFRB, USP8, IGFBP5, FBXW11, ERN1, DOK2, RAB35, ELMO1, RAB38, KPNB1, CARD11, RAB5C, DIABLO, CLEC16A, PSEN2, ITPR2, RASGRP2, STK4, PLD1, KRCC1, RASGRP4, STK3, RASGRP3, RAP1B, CCNB1, ZMAT1, TBXA2R, STK38, ABL1, DVL3, MBP, RIPK1, ECT2, RAB6A, MARK2, PRNP, RAB4B, IFT122, TNFRSF10B, CNOT10, CORO2A, NFKB1, NFKBIA, CNOT4, CNOT6, IRAK1BP1, CNOT7, ARHGAP30, SH3BP5L, PTPRA, CNOT1, GNAQ, RCAN3, BCL3, CNOT3, CDK2, PLEKHM1, NMUR1, CNOT8, LSM14A, BCAR3, MCTP1, PRKCSH, MAST3, YWHAB, DOCK8, TRADD, PTEN, ATP2A2, PKD2, PIK3CG, POLB, FLCN, CASP8, RASGEF1A, CASP3, CASP2, TLK1, ITGAV, ARHGEF11, KSR1, OXSR1, IRAK4, MASTL, ADRA2C, SPTB, TGFBR1, PJA2, TFDP1, ALS2, TFDP2, ADORA2A, PIK3C3, LCP2, LCP1, DOCK2, MET, BIRC3, PPP1R15A, CAMK2D, RGS19, ROCK2, TUFT1, RAB1B, IL2RG, RAB21, FZR1, GNG2, RAB20, PABPN1, RAB40C, CCL5, MKNK1, TIFA, MKNK2, CCL3, CCL2, NCAM1, ZNF622, RAB28, SH2B3, E2F7, SH2B2, E2F8, ARFGEF2, ANGPT1, CDC5L, TSHR, MAPK13, SNRK, P2RX4, TNIP2, ASB8, RAB13, RAB18, BAX, ASB7, CCM2, KRAS, PTPN6, TEK, ASB3]
GO:0030423;targeting of mRNA for destruction involved in RNA interference;7.0;1.0;0.8509193652572005;9.628524252492122;66.59596265062147;8.390779266560578;0.002228906937441061;0.7800242071602487;[DICER1]
GO:0061045;negative regulation of wound healing;7.0;0.7140352122741334;0.7079369713942671;8.89455507741192;107.66696239567408;5.587418885654044;0.0036035163374079447;0.6366602269110988;[FGA, THBD, PLAU, FGG, PRKCD, PLAUR, PTEN, CD9, WFDC1, AGER, CLASP1]
GO:0090502;RNA phosphodiester bond hydrolysis, endonucleolytic;8.0;0.6799073451904818;0.7149536725952409;8.878218658092228;231.13671471601307;5.395046993006588;0.007735937832006836;0.6509029541176994;[ERN1, BOP1, FEN1, LAS1L, EXO1, POP4, CPSF3, RPP21, RPSA, NOL9, DICER1]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[ANGPT1, SYK, PCSK9]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[PTGER4, CUEDC2, SERPINF1, PRKCD, GPS2, WFDC1, RORA, METRNL, AGER, NFKB1, IL22RA2, BCR, ABR, NLRP12, ADORA2A, NLRP7, PBK, NLRP3, TEK]
GO:2001183;negative regulation of interleukin-12 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;8.67846133901236;0.02523477878196853;0.8590579283277371;[TLR8]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[PTGER4, SUCNR1, FCER1G, CCL3L1, ITGA2, PARK7, PIK3CG, MAPK13, NFKBIA, C3, VAMP8, NLRP12, IL6, KARS, TNIP1, IL23A, HYAL2, NPPA, CCL3, TLR7, TLR10, GPSM3, CCR2]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[SPAG16, BCCIP, CIB1, CALML4, BICD1, TUBA1C, TUBA1B, TUBB6, KIF19, NUF2, ZNF207, FBXO5, NEFH, MAP1S, TUBG1, CKAP5, IQCG, EML3, NCOR1, ESPL1, KATNAL1, MAP7D1, MYH9, KIF2C, MAPRE3, KIF20A, VAMP4, MAPRE1, GAPDH, KPNB1, GAS8, PAFAH1B1, MCPH1, BIRC3, HDAC3, DCTN2, TUBGCP2, VPS4B, TUBD1, CCNB1, SPAST, KIF3B, LMNA, DISC1, CLASP1, MARK2, BBS2, RANBP3, UBE2B, CEP350, NDC80, RAB11A, CCDC88B, NSFL1C, CENPE, CCDC88A, NIN, WEE1, SON, CDK5, TTLL3, FES, KIF4A, CENPJ, TBCE, FGFR1OP, SPRY1, CALM1, SPC25]
GO:0009967;positive regulation of signal transduction;6.0;0.44130843764162375;0.5437745314109563;6.712834686611667;140.23187634019237;2.4492930892588385;0.004693434700611163;0.44837727507861835;[CYFIP2, MAML1, GFI1, RASSF2, TFG, ARL6IP5, CPNE1, IL12A, SKP2, EPHB4, CDK5RAP3, CSNK2A1, SLC35C2, PRKCE, PRKCD, MAPK8IP3, RC3H2, NUP93, DEPDC1B, SFRP1, TWSG1, SFRP2, KARS, IL23A, EPHA1, NAIP, ATF4, SEH1L, SHOX2, MTDH, C3, TP53BP2, NTSR1, PAG1, CREBBP, XBP1, JUP, TNFSF14, STARD10, GDF1, PUM2, CYLD, ARL2BP, TREML4, CALM3, CALM1, CD24, CALM2, EZH2, CDKN1C, HRK, CD40, ARHGAP1, SECTM1, ARHGAP6, BBC3, AKAP13, ING2, CASP10, C1QBP, HYAL2, TIMP2, SPIN1, CTSH, HRAS, HAVCR2, TMED4, DUSP5, MAP4K2, FCRL2, SEC13, DBNL, TNFRSF12A, RIPK3, SYK, SPHK1, FCRL3, ATPIF1, ZDHHC13, RHOC, ZDHHC17, VAV1, ITPKB, KIT, RAPGEF1, TLR7, ARHGEF5, GAS8, PAFAH1B1, HBEGF, SLC20A1, TUBD1, GPS2, RELA, ARNTL, BCLAF1, PLAGL2, CCL19, BID, DISC1, MAP3K3, CD74, MAP3K1, GSN, CCL20, RYK, GPR55, G0S2, PPP1CA, NLRP12, NEDD4, TAOK2, LIMS1, NCF1, CD80, CIB1, UBE3A, PARK7, IGF1R, EP300, PDE8A, MAP3K5, PDGFRB, USP8, FBXO18, IGFBP5, RPS7, ERN1, TBL1XR1, MADD, PPIF, CARD11, ANKRD17, CCL3L1, CLEC16A, STK4, AGER, RASGRP4, STK3, RAP1B, BAG4, UBD, UBR5, ABL1, DVL3, RIPK1, ECT2, CD300LF, UBE2I, BDNF, CAV1, TNFRSF10B, TNFRSF10A, NFKB1, SSH1, IL6, CXCL11, BMP2, CDK5, RHEB, SERINC3, IL7R, LSM14A, BCAR3, ITGB1, CXCL9, BMPR2, YWHAB, ITGB3, TRADD, USP34, PTEN, PTPN22, PKD2, PIK3CG, FLCN, PTBP1, CASP8, ADAMTS3, RASGEF1A, NUP62, CASP2, ITGAV, DACT1, FGA, KSR1, BUD31, FGG, PLAUR, ZFP91, ARNT, IRAK4, ADRA2C, YWHAZ, TGFBR1, DUSP22, TFDP1, ALS2, TFDP2, ADORA2A, CAT, ACPP, MET, BIRC3, BECN1, HDAC3, WBP2, CXXC5, ACVR1B, THBS1, P2RY8, CCL5, TP53INP1, CCL3, CCL2, CSK, ZNF622, SH2B3, SH2B2, SASH1, TBX1, TCF7L2, PDE6H, ANGPT1, SEMA4D, FBXL15, SOD1, P2RX7, CD4, P2RX5, P2RX4, VAPA, TNIP2, TSPAN17, ASXL2, BAX, KRAS, PTPN6, TEK, LTBR, TRIM32]
GO:0051497;negative regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;338.83785420150645;6.781341354126479;0.01134059804585365;0.7792270645443136;[DLC1, PPFIA1, WAS, MET, ARHGAP6, CLASP1]
GO:0001676;long-chain fatty acid metabolic process;8.0;0.6835726970475526;0.7167863485237763;8.866384200445225;93.73125239075797;5.049685808968129;0.0031371006648681556;0.6332411671050352;[ACOT7, ELOVL5, ACSL6, HSD17B4, ELOVL6, ACSL3, AIG1, ACOT2, DAGLB, SLC27A2, PAM, FADS1, ACOT4, MGLL, PTGES]
GO:0016241;regulation of macroautophagy;7.0;0.6729672293956388;0.6874029799550199;8.606873004960141;45.30384692040349;4.7081694254602375;0.0015162789856107417;0.5916953686275062;[BECN1, USP36, CALCOCO2, RAB1B, CLEC16A, VPS26A, VPS26B, MTM1, ERN1, CDK5, RHEB, CASP3, NEDD4, ATP6V0A2, EXOC4, CHMP4B, RAB3GAP2, MFN2, ULK1, CAPN1, GAPDH, RAB3GAP1, EXOC1, C9orf72]
GO:0050847;progesterone receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;54.01143535742291;7.697632086000634;0.0018077141342769656;0.7686572628545723;[WBP2, NEDD4, UBR5, UBE3A]
GO:0016485;protein processing;6.0;0.6519675769143192;0.6491041010473041;8.320191432841943;99.81063536400724;4.720827822332161;0.0033405721418933456;0.564543666965156;[CYFIP2, STOML2, PSEN2, PCSK9, ECE2, CLN3, CASP8, ADAMTS3, PLAU, PERP, CASP3, CAPN2, CASP2, CTSH, LONP2, PMPCB, CTSE, SEC11A, SEC11C, FGA, MME, RHBDF2, FGG, P2RX7, SPCS2, PIK3C3, METAP2]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[PDGFRB, PPP1R15A, CDCA2, PPP1R12A, FCRL3, PRKCD, PPP2R5D, PTBP1, PPP1R7, DLC1, CALM3, CALM1, CALM2]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[ERRFI1, RORA, BRCA1, PKD2, ELK1, AACS, PIK3CG, UBE2L3, AQP1, CASP8, SIN3A, CASP3, ACTR2, USP8, ABCC2, ANXA1, IGFBP5, ITGA2, SERPINF1, TMEM173, SIRT2, DNM2, SFRP1, XRN1, DDIT4, RAPGEF1, ATF4, COLEC12, ROCK2, ABCB4, ITPR2, LRP8, HSP90B1, RAP1B, CCNB1, GNG2, CCL5, ABL1, CCL3, CCL2, RAE1, SULT1A3, PCK2, JUP, CAV1, ATP2B4, MSN, CDC5L, GDAP1, NFKB1, SSH1, SOD1, NFKBIA, P2RX7, BMP2, RAD51, P2RX4, FOLR2, EZH2]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[ITGB1, FCER1G, SYNJ1, TFRC, SYK, CAV1, NEDD4, ITGB2, CD9, PICALM, DNM2]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[MARCKS, MYO1B, SWAP70, NEDD9, LCP1, RHOC, HSP90B1, RHOB]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CD80, LST1, SIRPG, CIB1, COMT, ADORA3, RPS6KA2, MYC, FNTB, TRIM24, IL12A, IGFBP5, SERPINF1, DICER1, SFRP1, TWSG1, SFRP2, KARS, SF1, PTGES, CCL3L1, STK4, STK3, TMEM127, TFAP2A, ZBTB17, PRNP, CAV1, IDH2, GLMN, EAF2, IFT122, IL6, BMP2, CDK6, CNOT7, TMEM115, GJB6, PEMT, CNOT8, CDKN1C, BTG2, CDKN1A, BMPR2, BTG1, PTEN, WFDC1, PTPRK, PKD2, FLCN, ING2, CASP3, NUP62, TIMP2, CTLA4, JARID2, HRAS, EMD, RBM5, HAVCR2, KLF10, KLF11, KLF13, ATPIF1, EMP3, PDCD1LG2, SIRT2, TGFBR1, NME1, GAL, TFDP1, ADORA2A, RAPGEF1, RARA, TAX1BP3, B4GALT7, GAS8, BECN1, THBS1, TP53INP1, LMNA, MFN2, CCL2, CSK, E2F7, CDKN2D, CDKN2C, WDR13, PER2, ITCH, FAP, NFIB, DLC1, CD9, BAX, MNDA, SPRY1, PTPN6, TRIM32]
GO:0014040;positive regulation of Schwann cell differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;471.693664190925;9.083926447120524;0.01578716244373315;0.8797934328124444;[DICER1, RELA]
GO:0002062;chondrocyte differentiation;4.0;0.8933024483968273;0.6966512241984136;9.446202695698167;21.066225782797595;6.039404009397101;7.050676185779127E-4;0.5588554019015759;[BMP2, SNX19, NFIB, CYTL1, RUNX2, RUNX1]
GO:0002063;chondrocyte development;4.0;0.8933024483968273;0.6966512241984136;9.474373572664863;32.15320660831846;6.943860283624253;0.001076138889173156;0.6051093378270707;[BMPR2, SFRP2, IMPAD1, SHOX2, EIF2AK3, RUNX2]
GO:1901522;positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus;12.0;0.7140352122741334;0.8051379187272112;9.260799472366804;1467.8987330058965;6.641579411751319;0.04912924957061573;0.7877709925721352;[CREB3, XBP1, BMP2, RXRA, EP300, RUNX2, RELA, ATF4]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, ARID4A, RORA, YEATS4, UBE3A, IKZF1, PARK7, IKZF2, ELK1, YY1, RPS6KA4, RPS6KA5, MYC, STK16, DPF2, EP300, SOX8, SOX6, IER5, HMGN3, ZNF564, IER2, CDK5RAP3, DDX17, MEF2B, FLT3LG, MED6, RUNX2, PIAS2, RUNX1, ARMCX3, SFRP2, IL23A, TBL1XR1, RFX4, HOXB4, ATF4, PAXIP1, MAX, SHOX2, ZNF24, RLF, SUPT6H, BCL2L12, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, ZBED1, RIPK1, CYTL1, PPARGC1B, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, JUP, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, NR4A2, BCL9, CDK8, IL6, STAG1, BMP2, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, ARF4, CIITA, CD40, SETD3, BMPR2, ONECUT2, ELL, THRA, CHD8, CHD7, DDX41, HOXC13, BRCA1, LDB2, AATF, PKD2, HOXC10, MED12, FLCN, NIPBL, SIN3A, HYAL2, MLX, HRAS, TEAD2, ZNF485, MKL2, KLF10, KLF13, RBM15, PPP1R12A, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, THRAP3, MTF2, TFEC, RARA, EAPP, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPE, CEBPG, GPS2, ACVR1B, RELA, ARNTL, RXRA, PLAGL2, MTA2, E2F7, E2F8, TBX1, ZNF462, TCF7L2, NFYC, ATAD2, CDC5L, ARID3B, GRHL1, USF2, POMC, KLF6, NFIA, TNIP1, NFIB, TNIP2, TTC5, NFIC, PSMC1, ASXL2, TAF7, CAMK1, TAF4, SSBP3, MIXL1]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[TFAP2A, PRNP, CDK5, CASP3, CCL3, CASP2, BAX, PCSK9, ATF4]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[BTG2, ANGPT1, WFS1, BDNF, NONO, KIF14, PARK7, CORO1A, SOD1, NR4A2, CLN3, ADORA2A, CCL2, BAX, KRAS, HYOU1, ADNP, SNCB, HRAS, NAIP, CPEB4]
GO:0006417;regulation of translation;7.0;0.5221699919663294;0.6120043612403652;8.01908634005802;212.8215771898108;3.9901762463137618;0.007122946661558481;0.554977164055858;[CYFIP2, BTG2, PIWIL4, EIF4E3, EIF4A3, CASC3, RBM3, EIF4ENIF1, MTRF1, PAIP2B, C1QBP, UPF1, EIF5B, RPS9, IGFBP5, ITGA2, SECISBP2, MIF4GD, ILF3, XRN1, RARA, ETF1, EIF4E2, GAPDH, ATF4, PPP1R15A, MTPN, CDC123, POLDIP3, NOLC1, THBS1, FXR1, ATXN2, RXRA, CCL5, MKNK1, TPR, MKNK2, POLR2G, EIF2B4, KLHL25, YTHDF3, EIF2AK3, CNOT10, UPF3A, EIF2S1, PUM2, PPP1CA, PER2, CNOT6, IL6, CNOT7, CNOT1, CAPRIN1, BCL3, CNOT3, ACO1, CNOT8, KBTBD8, LSM14A, EIF4G2, TNRC6A, CPEB4, TNRC6B]
GO:0002731;negative regulation of dendritic cell cytokine production;8.0;0.8933024483968273;0.8216512241984136;9.54514264355307;385.9057217908713;9.083926447120524;0.012915917215738997;0.839552420951524;[JAK3]
GO:2000778;positive regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.0674169630446;6.599019797332524;0.02068616022119099;0.7527151911823093;[XBP1, HYAL2, TLR8, MBP]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[IGFBP5, H3F3A, SHOX2, HSD17B4, RRBP1, HSPE1, SND1, RUNX2, RPS15, SFRP1, BMP2, TP53INP2, CAT, TMEM119, CCL3, SOX8]
GO:0070588;calcium ion transmembrane transport;9.0;0.7140352122741334;0.7532582313173557;9.078477915572849;116.6808485568922;4.562137870071484;0.003905202995253044;0.629548568016852;[STOML2, ATP13A1, PRKCE, CACNA2D3, ATP2B4, ITPR2, ATP2A2, PKD2L1, ATP2C2, PKD2, TRPC4AP, P2RX7, P2RX4, GRIN3A, CCL3, PMPCB, ITGAV, CCL19, ATP13A3, TRPM6]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[ITGB3, KIF14, PARK7, STK4, THBS1, STK3, ABL1, NEK1, NCKAP1L, RIPK1, CCL19, ECT2, MARK2, MAP3K5, MAP3K3, DUSP5, PRNP, MAP4K2, CD74, MAP3K1, DBNL, PDE6H, ANGPT1, RIPK3, SYK, PRKCD, ZFP91, TNFRSF10B, TNFRSF10A, PILRB, OXSR1, ADRA2C, MAPK8IP3, TGFBR1, SOD1, ERN1, P2RX7, CCDC88A, BMP2, KARS, TAOK2, KIT, MADD, RAPGEF1, ADNP]
GO:2000650;negative regulation of sodium ion transmembrane transporter activity;10.0;0.8259837884571596;0.8282329060895002;9.464221201200845;676.2962608223798;7.292166977892469;0.02263502722260573;0.7881627702307852;[CAMK2D, PRKCE, NEDD4, PCSK9]
GO:0045959;negative regulation of complement activation, classical pathway;11.0;0.9326813400603323;0.8987696223598284;9.612263731620342;2165.9397258078825;8.67846133901236;0.07249205340359062;0.8762458687964789;[CR1]
GO:0035771;interleukin-4-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;8.390779266560578;0.00101047745553359;0.7800242071602487;[IL4R, IL2RG, JAK3]
GO:0045957;negative regulation of complement activation, alternative pathway;11.0;0.9326813400603323;0.8987696223598284;9.608721625195942;1800.6019443914147;9.777073627680469;0.060264526642238345;0.9324289523296623;[CR1]
GO:0031054;pre-miRNA processing;9.0;1.0;0.896240625180289;9.628524252492122;237.27965971438954;7.212124270218933;0.007941536672810924;0.7650689957573628;[DICER1]
GO:0009267;cellular response to starvation;6.0;0.6369964171292115;0.6416185211547503;8.460919092337061;112.76702064936369;4.807260328104469;0.0037742106974044997;0.5689638293298743;[PLEKHF2, BECN1, CDKN1A, SEH1L, BMPR2, MAX, CLEC16A, PCSK9, COMT, WRN, LAMP2, FADS1, ATG5, MAP3K5, KLF10, GABARAPL1, XBP1, EIF2AK3, EIF2S1, SFRP1, TBL2, MARS, PIK3C3, CPEB4, ATF4]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[ITGB2, TLR8, TLR7]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TLE4, XBP1, TFRC, PMM1, XRCC5, EED, PRDM5, CACYBP, BSPRY, SRM, BCLAF1, RNF138, PIGA, MTF2, ADAM23, JARID2, NEFH]
GO:0010922;positive regulation of phosphatase activity;9.0;0.7586651285174919;0.775573189439035;9.267510906954792;265.2783726737478;6.311337724880743;0.008878628398354923;0.7190027299379095;[PDGFRB, PPP1R15A, BMP2, PPP1R12A, RIPK3, ITGA2, FCRL3, CALM3, CALM1, CALM2, PPARGC1B]
GO:0006309;apoptotic DNA fragmentation;9.0;1.0;0.896240625180289;9.628524252492122;682.1166149099336;7.004484905440688;0.022829829235937554;0.7544503089863854;[FEN1, DFFA, ENDOG, CASP3, DICER1, DNASE1L3, KPNB1]
GO:0001658;branching involved in ureteric bud morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.015873511986907;0.0017907488225476112;0.6585714164269392;[LAMA5, BMP2, MYC, PKD2]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[PTGER4, CXCL6, SCARB1, CD40, CXCL9, CEBPE, GFI1, CD80, ABCB4, ATP2A2, PTPN22, COMT, LIAS, RELA, ABR, THBD, CASP8, PABPN1, NLRP7, TBXA2R, CASP3, ABL1, NLRP3, CCL2, IL12A, HAVCR2, PCK2, UPF1, XBP1, ABCC2, CCL20, TNFRSF10B, TNFRSF10A, PDCD1LG2, NFKB1, BCR, P2RX7, IL6, CXCL11, TNIP1, TNIP2, GJB6, RARA, LTBR, NFKBIB, PTGES]
GO:0030199;collagen fibril organization;5.0;1.0;0.7902410118609202;9.628524252492122;53.964823970696955;5.9928839937622085;0.0018061540931107725;0.5967173779995258;[COL1A2, SFRP2, ADAMTS3, COL5A1, ATP7A, TGFBR1]
GO:1902230;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;831.2496569477559;6.409777797693995;0.02782117794191935;0.7430373465201421;[BCL2L12, CDKN2D, CD74, ING2, SFRP2, BID, TRIM32]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[TCF7L2, DTX3L, EPB41, BDNF, CAV1, PARK7, TMEM173, STK4, STK3, PPP2CA, BMP2, GNL3L, CDK5, ABL1, EP300, MAPRE3, TRIB3, MAPRE1, DACT1]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SMG1, CAMK2D, STK4, ACVR1B, IGF1R, MKNK1, MKNK2, STK16, TRIM24, ABL1, RIPK1, CSK, PIM3, JAK3, MARK2, EPHB4, PDGFRB, MAP3K3, RIPK3, SYK, CAD, EIF2AK3, VRK1, VRK2, CLK4, EIF2S1, CLK3, CLK1, ERN1, BCR, CDK5, FES, CAMK4, TAOK2, KIT, ULK1, TEK, EPHA1, CSNK1G2]
GO:0048711;positive regulation of astrocyte differentiation;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;472.09912929902924;7.069023426578259;0.015800732996006494;0.7767511986393403;[BMP2, AGER]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[P2RX7, RIPK3, TNFSF14, CASP3, NCKAP1L, CORO1A, JAK3, RC3H2]
GO:0000023;maltose metabolic process;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;66.17358362000121;8.67846133901236;0.002214770291402649;0.7669372290569613;[MGAM]
GO:0032526;response to retinoic acid;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;43.78950961223322;5.123113277522946;0.0014655954787213788;0.5522372631225753;[TBX1, PDGFRB, CDKN2D, SERPINF1, TWF2, ZNF35, AQP3, GDAP1, AQP1, SETX, RXRA, SYNJ1, RARA, CTSH, TEAD2, PTGES]
GO:0045332;phospholipid translocation;8.0;1.0;0.875;9.628524252492122;116.86638763413639;6.641579411751319;0.003911412821194078;0.7146506799819907;[P2RX7, ABCC1, TMEM30A, ABCB4, ATP9A]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[CDKN2D, CSNK2A1, TNFSF14, PLAUR, TNFRSF10B, TNFRSF10A, SERPINB9, NLRC4, PARK7, UBE2Z, THBS1, AQP1, VIL1, BCL2L12, SFRP2, ADORA2A, BIRC6, RFFL, NAIP, BIRC3]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[VPS29, CHD8, USP34, PTEN, KLHL12, VPS26A, PRICKLE1, APCDD1, MED12, GNG2, GNAT2, RNF138, MYC, GRK6, AP2S1, SPIN1, DVL3, DISC1, GPC6, MARK2, DACT1, TLE4, TCF7L2, CSNK2A1, UBE2B, RYK, FBXW11, FZD6, SENP2, AES, DDB1, NR4A2, CYLD, BCL9, SFRP1, SFRP2, CCNE1, SDC1, TAX1BP3, CALM1, CD24, MET, CSNK1G2, TNRC6A, CSNK1G1, TNRC6B]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[BMPR2, SHOX2, TWF2, TRAK1, LRP8, RAB21, NCKIPSD, DVL3, SCARF1, MARK2, ARSB, ACTR2, TMEM30A, SEMA4D, TNFRSF12A, BDNF, SERPINF1, RAB11A, NME1, SETX, FES, RUFY3, CAPRIN1, RAPGEF1, CAMK1, ADNP, MEGF8, PAFAH1B1, EZH2]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[DIABLO, PDCD6, TRADD, EIF2AK3, TNFRSF10B, TNFRSF10A, NLRC4, HSPE1, BBC3, NLRP12, CASP8, CASP10, CASP3, DLC1, NLRP3, CTSH, BAX, RIPK1, BID]
GO:0048041;focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;92.53238439646684;6.599019797332524;0.0030969756320103773;0.712474179321389;[LAMA5, ITGA2, RCC2, DLC1, TAOK2, TESK2, PTPRK, ARHGAP6]
GO:0015867;ATP transport;9.0;0.8933024483968273;0.8428918493787028;9.517298617381897;171.59409552327534;7.379178354882098;0.005743099952504153;0.7736121494158466;[SLC25A24]
GO:0035115;embryonic forelimb morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;58.806290969860136;6.343086423195323;0.001968193636535348;0.647506047256038;[TFAP2A, NIPBL, SHOX2, IFT122, RUNX2]
GO:0015866;ADP transport;9.0;0.9326813400603323;0.8625812952104552;9.567899630675686;156.75594700474343;7.57984905034425;0.005246480475055576;0.7838744581139225;[SLC25A24]
GO:0055007;cardiac muscle cell differentiation;6.0;0.7866048967936545;0.7164227609869718;9.0689084645567;45.916641199513585;6.409777797693995;0.0015367886586535107;0.6509166472493662;[ITGB1, AKAP13, BMP2, RXRA, RARA, CACYBP, ARID1A, SOX6]
GO:0051567;histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.56398573135455;955.3390821452521;7.474488534686424;0.03197433933004731;0.8146746435927894;[SUV39H1, PRDM5, ARID4A]
GO:0060397;JAK-STAT cascade involved in growth hormone signaling pathway;8.0;1.0;0.875;9.628524252492122;26.42836680105094;7.212124270218933;8.845336528452411E-4;0.7438283705770736;[JAK3]
GO:0060272;embryonic skeletal joint morphogenesis;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;46.18089108149027;7.292166977892469;0.0015456328643938164;0.6960420709600095;[SHOX2]
GO:0060395;SMAD protein signal transduction;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;5.734022359845919;7.75488093814194E-4;0.5834791820027497;[NUP93, BMP2, GDF1, LNPEP]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[USP8, SFRP1, SFRP2, JUP, TBL1XR1, CAV1, USP34, UBR5, NFKB1, NAIP, ARNTL, DACT1]
GO:0046425;regulation of JAK-STAT cascade;8.0;0.7586651285174919;0.754332564258746;9.158520623246385;46.16872612457469;4.77312732173501;0.0015452257142336023;0.6190979532066485;[PIGU, CD40, CAV1, GFRA2, IL22RA2, PPP2CA, IL6, CNOT7, ARL2BP, IL23A, CCL5, BCL3, KIT, IL12A, JAK3, SH2B2]
GO:1900745;positive regulation of p38MAPK cascade;12.0;1.0;0.9481203125901445;9.628524252492122;1761.632567075866;6.7325511899570465;0.05896025665364957;0.7924232935401965;[MAP3K3, BMP2, KARS, NCF1, AGER, SASH1, MAP3K5]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[TCERG1, ZNF175, RPL3, RNH1, GFI1, EIF4A3, PPP2R2A, IKZF1, IKZF2, RPS15, RPS6KA5, MYC, SAP130, DPF2, TRIM24, CPNE1, SOX8, DIP2A, TRIM27, SOX6, DDX17, ZNF282, SLC35C2, SFMBT2, SERPINF1, ZNF12, DICER1, HCFC2, SND1, RUNX2, THAP1, RUNX1, EID1, SFRP1, SFRP2, XRN1, HOXB4, TRIB3, RPL29, NAIP, ATF4, FOXG1, MEPCE, SHOX2, ZNF24, GLG1, MTDH, FXR1, DHX34, HIVEP1, HESX1, A2M, PPARGC1B, BBS2, CREBBP, XRCC6, ZNF263, XRCC5, BCL11A, H3F3A, EIF2AK3, UPF3A, QARS, PKIA, DCP1A, RCOR3, ZNF136, EZH2, CPEB4, CC2D1B, CDKN1C, HBS1L, BTG2, CDKN1A, SMG1, TCF25, SUV39H1, OTUD7B, BRCA1, PTPRK, SMG5, NIPBL, C1QBP, MLX, CIC, JARID2, HRAS, HAVCR2, UPF2, ZNF485, UPF1, TSC22D4, HELLS, HBZ, TSC22D3, SIRT7, PPHLN1, SIRT2, NME1, AES, NCOR2, NCOR1, NFX1, PTRH2, CSDE1, MTF2, DEPDC1, RARA, DCP2, ZNF350, GPS2, PRICKLE1, RELA, ARNTL, PPP2CA, BCLAF1, RXRA, EXOSC3, DCPS, RPL19, YTHDF3, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, NEDD4, LIMS1, NAB1, GMNN, UBE2D3, PRDM5, ARID4A, UBP1, ZBTB20, CASC3, PARK7, UBE2Z, YY1, EIF4ENIF1, PAIP2B, WWC3, EP300, ZNF564, TLE4, RPS9, IGFBP5, RPS7, FBXW11, ZBTB32, SARS, RPSA, RNF40, ERN1, OLFM1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, MRTO4, TIMELESS, MYADM, ADNP, PPID, MAX, SUPT6H, BCL2L12, CCNB1, NLRP7, BAG3, TPR, SUDS3, BPTF, WDTC1, TFAP2A, PRNP, DR1, UBE2I, PNPT1, CBX4, WFS1, CBX3, NONO, CAV1, NFXL1, CNOT10, HELZ, LSM5, EIF2S1, NFKB1, CDK9, CNOT4, NR4A2, CNOT6, BMP2, PAN3, CNOT7, CDK5, YEATS2, CNOT1, CAPRIN1, SP3, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, SKIV2L, CNOT8, PHF19, PICALM, USP36, CIITA, PIWIL4, THRA, YWHAB, CHD8, PTPN22, LDB2, FLCN, PTBP1, SIN3A, LRRFIP1, HIF1AN, DACT1, KLF10, KLF11, KLF12, CR1, PEG3, RFC1, H2AFY, EED, DIS3, PAPD4, ARID1A, ZFP90, DUSP22, RBL1, TFDP2, THRAP3, LCOR, ETF1, BIRC6, EIF4E2, EAPP, GAPDH, MCPH1, BIRC3, HDAC3, HDAC1, NLRC4, CXXC5, ACVR1B, LRP8, THBS1, DNAJB1, U2AF2, DNAJB5, TP53INP1, CCL3, SAP18, POLR2G, RBBP7, MTA2, E2F6, E2F7, ZNF189, E2F8, TCFL5, IRX1, RNF20, SPEN, TCF7L2, SEMA4D, RPL23A, PNRC1, PNRC2, TAF7, TNRC6A, TRIM33, TNRC6B]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[CCNF, UBE2D3, KIF14, BUB1B, UBE3A, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, SEC13, RNF44, FBXO18, FBXW11, UBE4A, RAD23A, KCTD2, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, RNF121, DERL3, RNF38, DERL2, PSMB10, PSMA7, ANAPC11, ARNTL, HSP90B1, AMN1, CCNB1, FZR1, ZNRF2, PSMB5, RMND5A, PSMB1, UBQLN1, RFFL, UBE2I, LRRC29, UBE2B, WFS1, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, BTBD6, MARCH6, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, NEDD4, CDC16, FBXL3, MAD2L1]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[THRA, CASP3, SP3, ATPIF1, CEBPG, KIT, ACIN1, IKZF1, JAK3, NFE2L1]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[SPEN, GALNT11, CREBBP, MAML1, NOTCH2NL, PSEN2, DTX2, MIB1, ITCH, BMP2, PERP, MYC, EP300]
GO:0010989;negative regulation of low-density lipoprotein particle clearance;6.0;1.0;0.8231203125901445;9.628524252492122;57.61250424992052;8.16763571524637;0.0019282386693572648;0.7408135829017477;[MYLIP, PCSK9, CSK]
GO:0045221;negative regulation of FasL biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;967.9208223894049;9.777073627680469;0.032395438853188026;0.896240625180289;[JAK3]
GO:0010626;negative regulation of Schwann cell proliferation;10.0;0.9326813400603323;0.8815816818910864;9.590783924509275;548.146883897569;7.9853141584524145;0.018345982903883885;0.8236103492792612;[DICER1]
GO:0043162;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;9.0;1.0;0.896240625180289;9.628524252492122;157.5507831317809;7.004484905440688;0.005273082924921447;0.7544503089863854;[VPS4B, NEDD4, VPS37A]
GO:0034379;very-low-density lipoprotein particle assembly;7.0;1.0;0.8509193652572005;9.628524252492122;106.00255471231415;7.474488534686424;0.003547810110115553;0.7331650565203278;[SOAT1, ACSL3]
GO:0033168;conversion of ds siRNA to ss siRNA involved in RNA interference;9.0;1.0;0.896240625180289;9.628524252492122;118.17267523850805;9.777073627680469;0.003955133091729879;0.896240625180289;[DICER1]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[SMG1, CAMK2D, MAST3, ROCK2, STK4, RPS6KA4, CCNB1, RPS6KA5, MKNK1, STK38, MKNK2, STK38L, RIPK1, MARK2, SYK, PRKCE, PRKCD, EIF2AK3, CDC7, VRK1, VRK2, MASTL, TGFBR1, MAPK13, CLK1, ERN1, CDK5, CAMK4, CDK2, ULK1, PKN2, CAMK1, CSNK1G2, CSNK1G1]
GO:0010862;positive regulation of pathway-restricted SMAD protein phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1012.5567145242198;5.905872616772578;0.033889361993245395;0.7172676121338334;[TWSG1, BMP2, BMPR2, GDF1, ACVR1B, TGFBR1]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[CAMK2D, CSNK2A1, ROCK2, CAD, PRKCD, VRK1, OXSR1, ACVR1B, TGFBR1, CLK1, CDK5, ULK1, CAMK1, MARK2]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[PTGER4, MCTP1, PTEN, MIA3, WASL, PTPRK, THBS1, ABR, FLCN, RRAS, TBXA2R, ADORA3, HYAL2, TP53INP1, ARHGDIB, CCL2, TIMP1, CLASP1, RNF20, STARD13, IGFBP5, JUP, SERPINF1, IDH2, RHOB, BCR, NISCH, SFRP1, SFRP2, DLC1, EPHA1]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[CXCL6, SCARB1, GPI, CD40, CXCL9, BMPR2, ONECUT2, DOCK8, ITGB3, PDCD6, CIB1, MIA3, CXCL14, IGF1R, PREX1, NIPBL, PLAU, C1QBP, TMSB4X, CTSH, IL12A, ITGAV, CPNE3, ATP7A, GTSE1, HRAS, GPSM3, CCR2, SEMA6B, PDGFRB, ANXA1, IGFBP5, ITGA2, SPHK1, SWAP70, PRKCE, TGFBR1, RHOB, PTP4A1, CREB3, KARS, IL23A, RUFY3, KIT, MYADM, EPHA1, MAPRE1, MET, CBLL1, HBEGF, CD151, SEMA3C, ROCK2, CD99L2, ACVR1B, THBS1, CORO1A, BAG4, CCL5, ABL1, CCL3, NCKAP1L, CCL19, AAMP, CLASP1, SASH1, MAP3K3, CD74, XBP1, ANGPT1, SEMA4D, TNFSF14, CCL20, SEMA4B, RAB11A, SSH1, VIL1, IL6, CXCL11, BMP2, P2RX4, SP1, FGFR1OP, TEK, TRIM32]
GO:0042998;positive regulation of Golgi to plasma membrane protein transport;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;462.69914382070084;8.67846133901236;0.015486123941484539;0.8400575416471059;[ACSL3]
GO:0042758;long-chain fatty acid catabolic process;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;527.2545631336777;7.474488534686424;0.01764673572978441;0.7784863164434164;[AIG1]
GO:0061036;positive regulation of cartilage development;6.0;0.8259837884571596;0.7361122068187242;9.36615998802463;85.07595514026741;6.375876246018314;0.00284741565515604;0.6491829203200885;[BMP2, BMPR2, SOX6, RUNX2, RELA]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[CDKN2D, CD4, SFRP1, ABCB4, AQP3, GDAP1]
GO:1901165;positive regulation of trophoblast cell migration;8.0;1.0;0.875;9.628524252492122;361.5862730580211;7.9853141584524145;0.012101967152733394;0.7833693374183408;[C1QBP, ACVR1B]
GO:0045589;regulation of regulatory T cell differentiation;9.0;0.7866048967936545;0.7895430735771163;9.517298617381897;133.46855707074621;6.518977089658987;0.004467072491254967;0.7296214167088868;[CR1, CTLA4, RUNX1]
GO:0009972;cytidine deamination;11.0;1.0;0.9324289523296623;9.628524252492122;2918.4586051188953;7.474488534686424;0.09767818307110789;0.8146746435927894;[APOBEC3F, CDADC1, APOBEC3H, APOBEC3A]
GO:0006226;dUMP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;6271.9915988638395;8.16763571524637;0.2099179143880009;0.8658135829017477;[DUT, CDADC1]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[BECN1, ZNF175, CD40, CXCL9, DDX41, ZC3HAV1, SAMHD1, LYST, RELA, CCL5, HYAL2, CFL1, NLRP3, IL12A, BANF1, CCL19, IFNAR2, DDX17, IVNS1ABP, APOBEC3F, DTX3L, APOBEC3H, MX2, TMEM173, UNC13D, ITCH, ILF3, IL6, CDK6, CNOT7, GPAM, POLR3B, POLR3C, IL23A, BCL3, POLR3E, DDIT4, TLR8, TLR7, SERINC3, LSM14A, APOBEC3A, XPR1, EXOC1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TCERG1, ZNF175, GFI1, UBE2D3, PRDM5, ZBTB20, IKZF2, YY1, MYC, SAP130, WWC3, EP300, SOX8, TRIM27, SOX6, ZNF564, TLE4, ZBTB32, SARS, DICER1, HCFC2, THAP1, RUNX1, EID1, BRMS1, TBL1XR1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, MAX, FOXG1, MEPCE, SHOX2, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, WDTC1, TFAP2A, DR1, CREBBP, ZNF263, UBE2I, CBX4, WFS1, BCL11A, CAV1, NFXL1, NFKB1, NR4A2, BMP2, CNOT7, YEATS2, CNOT1, PKIA, SP3, CDK2, NFE2L3, RCOR3, ZNF136, EZH2, CC2D1B, CIITA, BTG2, THRA, TCF25, SUV39H1, CHD8, OTUD7B, LDB2, FLCN, NIPBL, SIN3A, C1QBP, MLX, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, KLF10, KLF11, HBZ, KLF12, PEG3, RFC1, H2AFY, EED, TSC22D3, SIRT7, ARID1A, SIRT2, ZFP90, AES, DUSP22, NCOR2, NCOR1, RBL1, NFX1, MTF2, RARA, LCOR, EAPP, MCPH1, HDAC3, ZNF350, HDAC1, GPS2, CXXC5, LRP8, RELA, DNAJB1, RXRA, DNAJB5, RBBP7, MTA2, E2F6, E2F7, ZNF189, E2F8, TCFL5, IRX1, SPEN, TCF7L2, SEMA4D, PER2, GFI1B, NFIA, NFIB, NFIC, NEDD4, TAF7, TRIM33]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[ERRFI1, XBP1, SP1, MARS, PPAT, RAB13, PTEN, PCSK9, TRIB3, RAB8B, WDTC1, PCK2]
GO:1900748;positive regulation of vascular endothelial growth factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;214.13840462141061;8.16763571524637;0.00716701969062638;0.7686126355688037;[ADAMTS3]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[OLFM1, BMP2, TGFBR1, EZH2]
GO:1902807;negative regulation of cell cycle G1/S phase transition;8.0;0.7763722522362496;0.7631861261181248;9.303101852057495;106.39519485100838;5.202362649177086;0.003560951422204466;0.6410490678135203;[BTG2, CDKN1A, PCNA, PTEN, PKD2, CCNB1, CASP2, EP300, CCL2, GTSE1, E2F7, E2F8, DACT1, CDKN2D, CNOT10, CNOT4, CNOT6, TFDP1, RBL1, CNOT7, TFDP2, CNOT1, CTDSP2, RFWD3, CNOT3, CDK2, BAX, ZNF655, CNOT8, EZH2]
GO:0031658;negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle;13.0;1.0;0.9625549647676366;9.628524252492122;3330.314475181895;7.8311634786251565;0.11146262839589782;0.8630410292508717;[CDKN2D, CDKN2C, CDK6, PTEN]
GO:0035338;long-chain fatty-acyl-CoA biosynthetic process;8.0;1.0;0.875;9.628524252492122;500.3176215265477;6.8867018697843045;0.016745180535867314;0.7271862538851576;[ELOVL5, ACSL6, ELOVL6, ACSL3]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[SERPINA3, CSTB, CSTA, ITIH2, SERPINA10, WFDC1, NLRC4, PARK7, UBE2Z, THBS1, AQP1, C3, BCL2L12, NLRP7, TIMP2, TIMP1, RFFL, A2M, CDKN2D, SERPINB1, CR1, CSNK2A1, AMBP, TNFSF14, SERPINF1, PLAUR, TNFRSF10B, TNFRSF10A, SERPINB9, SERPINB6, VIL1, SFRP2, ADORA2A, COL7A1, BIRC6, GAPDH, NAIP, PICALM, BIRC3]
GO:0015721;bile acid and bile salt transport;9.0;0.9326813400603323;0.8625812952104552;9.5544162803384;89.96332036720499;6.375876246018314;0.003010991370958501;0.722303232910233;[RXRA, ABCC2, SLC10A2]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[TCERG1, ZNF175, CCNK, CCNH, GFI1, ZNF292, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, CPNE1, SOX8, TRIM27, SOX6, IER5, ATXN7L3, IER2, DDX17, ZNF18, SAP30BP, MEF2B, CSNK2A1, ZNF282, RFX1, ZNF12, SND1, THAP1, RUNX1, EID1, EWSR1, RFX4, HOXB4, TRIB3, BCORL1, ASF1B, SF1, ATF4, ZNF276, ZNF395, ZNF274, ZNF394, PAXIP1, FOXG1, MYCBP2, ZNF20, CDCA7, ZNF23, RPAP1, ZNF24, ZNF25, COMMD9, RAD21, HLTF, HIVEP1, HESX1, HOXC4, ZBED1, HIVEP2, PPARGC1B, ZNF264, ZNF143, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, BCL11A, INTS3, PBX3, EAF2, ZNF35, FLI1, SOX30, STAG1, ZNF30, ZNF813, INTS4, INTS7, INTS6, RCOR3, ZNF136, INTS8, EZH2, CC2D1B, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, TCF25, SUV39H1, INTS10, ATF7IP2, HOXC13, BRCA1, WASL, WDR43, HOXC10, NIPBL, CHAF1B, ING2, ZMYM2, SCML1, SCML4, C1QBP, HYAL2, MLX, SPIN1, CIC, JARID2, ZNF485, BRD3, TSC22D4, HELLS, COMMD3, BAZ1A, COMMD1, SIRT7, PPHLN1, PPRC1, ZFX, MED29, SIRT2, MED28, AES, NCOR2, NCOR1, NFX1, TFEC, MED20, DEPDC1, VGLL4, ZNF234, ZNF350, HEATR1, GPS2, ZNF2, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, TCEAL3, PLAGL2, GPBP1L1, DEDD, ZNF101, ZNF585A, ZNF462, ZNF581, NFYC, ATAD2, GRHL1, GTF2H4, PER2, ZNF33A, GFI1B, NFIA, NFIB, NFIC, MARS, PKN2, ZNF213, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, NAB1, PRDM5, ARID4A, UBP1, ZBTB20, YEATS4, YY1, STK16, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZNF561, ZNF680, ZBTB32, SARS, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, ZNF302, BPTF, TRAPPC2, TFAP2A, IVNS1ABP, ZBTB17, DR1, CBX4, CBX3, NONO, NFXL1, CNOT10, NFKB1, CDK9, NR4A2, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP4, SP3, MAFF, BCL3, CNOT3, ZFP64, ZNF658, NFE2L3, ZNF777, ZNF655, CNOT8, TMEM18, MNAT1, ZNF654, BRWD1, ZNF532, ZNF410, NFE2L1, ZSCAN2, ZNF652, PHF19, NFKBIB, PHTF2, CIITA, BMPR2, ONECUT2, THRA, CHD9, CHD8, CDCA7L, CHD7, CHD1, AFF4, LBH, SIN3A, ZNF407, NUP62, NFKBIZ, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, MKL2, KLF10, KLF11, KLF12, TBP, KLF13, RFC1, EED, BUD31, MKL1, ARNT, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, POLR1B, ZNF638, ZNF516, LCOR, ZNF511, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPE, CEBPG, CXXC5, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2E, SAP18, POLR2G, PCBD1, ASCC3, RBBP7, POLR2I, E2F6, E2F7, POLR2K, ZNF189, E2F8, TCFL5, ZNF286A, TBX1, POLR2J3, SPEN, TCF7L2, CHURC1, TAF15, EYA2, CDC5L, ARID3B, DEK, USF2, PNRC1, MAPK13, PNRC2, KLF6, POLR3B, POLR3C, TNIP2, POLR3E, ASXL2, TAF7, MNDA, TAF5, TAF4, SSBP3, TRIM33]
GO:0006231;dTMP biosynthetic process;12.0;0.9326813400603323;0.9144609826203107;9.610505746989444;6271.9915988638395;8.390779266560578;0.2099179143880009;0.8772251544931927;[CDADC1]
GO:0045356;positive regulation of interferon-alpha biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;8.390779266560578;0.0286306378699575;0.8041048419030481;[TLR8, TLR7]
GO:0048743;positive regulation of skeletal muscle fiber development;9.0;1.0;0.896240625180289;9.628524252492122;623.8299612915386;7.697632086000634;0.02087902739391249;0.7898978880348613;[SHOX2]
GO:0002430;complement receptor mediated signaling pathway;9.0;0.9326813400603323;0.8625812952104552;9.57973408832269;218.73839564357212;7.212124270218933;0.007320977250414979;0.7650689957573628;[CR2, CR1]
GO:0045359;positive regulation of interferon-beta biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;7.8311634786251565;0.0286306378699575;0.7754860644832351;[TLR8, TLR7]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[IL6, ANXA1, CCL3L1, CCL20, CCL5, CCL3, CCL2, CCL19, CCR2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[CIB1, PARK7, UBE2Z, IGF1R, AQP1, MYC, CFL1, SOX8, PIM3, EPHB4, IER3, PDGFRB, CSNK2A1, PRKCD, FLT3LG, THOC6, SFRP1, CFDP1, SFRP2, PPIF, VDAC2, ADNP, EPHA1, PPID, NAIP, PSEN2, CORO1A, MTDH, HSP90B1, BCL2L12, BAG4, HSPH1, BAG3, BAG1, ABL1, NCKAP1L, RIPK1, NTSR1, ATG5, TFAP2A, IVNS1ABP, PRNP, PRELID1, XBP1, UBE2B, CBX4, TNFSF14, WFS1, BDNF, NONO, RHBDD1, CAV1, TNFRSF10B, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, NR4A2, IL6, SON, COPS5, QARS, BCL3, HYOU1, MNAT1, IL7R, CPEB4, AVEN, ITGB1, ARF4, BTG2, CDKN1A, DOCK8, TRADD, KIF14, PTEN, BRCA1, AATF, PIK3CG, ING2, CASP8, NNT, SIN3A, CASP3, NUP62, CASP2, CTSH, ITGAV, TIMP1, HRAS, JAK3, TSC22D4, FGA, DFFA, FCER1G, ANXA1, SPHK2, SPHK1, TSC22D3, FGG, PLAUR, SERPINB9, YWHAZ, TGFBR1, DDB1, ITPKB, CREB3, ADORA2A, PTRH2, KIT, CAT, TMBIM1, RARA, BIRC6, MET, BIRC3, BECN1, HDAC3, HDAC1, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL2, CCL19, RFFL, SNCB, BID, TBX1, CDKN2D, TCF7L2, CD74, ANGPT1, SEMA4D, EYA2, RYK, SYVN1, SOD1, ITCH, GPAM, TNIP2, BAX, KRAS, ERCC5, PDCD1, TEK, CIAPIN1, TRIM32, MAD2L1]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CXCL6, CXCL9, CXCL11, CCL3L1, CCL20, CCL5, CCL3, CCL2, CIB1, CCL19, CCR10, CCR2]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[PDCD6, PARK7, UBE2Z, PREX1, RASSF2, RPS6KA2, MYC, ARL6IP5, IL12A, MAP3K5, PDGFRB, ENDOG, FBXO18, RPS7, PRKCD, TIAM2, SFRP1, BRMS1, SFRP2, PPIF, PPID, ATF4, DIABLO, STK4, STK3, ABR, UBD, TP53BP2, NLRP2, ABL1, NLRP3, RIPK1, SUDS3, ECT2, NTSR1, TFAP2A, PRNP, PRELID1, CAV1, EIF2AK3, TNFRSF10B, TNFRSF10A, EIF2S1, CYLD, IL6, BMP2, CDK5, SERINC3, HRK, ITGB1, CD40, BTG1, YWHAB, TRADD, PTEN, PCSK9, BBC3, FLCN, AKAP13, CASP8, CASP10, C1QBP, CASP3, HYAL2, CASP2, CTSH, CTLA4, RBM5, ARHGEF11, KLF11, DFFA, C3orf38, ANXA1, TNFRSF12A, RIPK3, ATPIF1, PLAUR, YWHAZ, SIRT2, VAV1, TGFBR1, VAV2, RHOB, DNM2, AES, GAL, TFDP1, TFDP2, ADORA2A, PTRH2, ARHGEF1, GAPDH, ARHGEF5, ITGB3BP, CAMK2D, NLRC4, THBS1, BCLAF1, CCL5, TP53INP1, CCL3, SAP18, PLAGL2, MFN2, CCL2, ZNF622, BID, GSN, G0S2, HSPE1, SOD1, PPP1CA, P2RX7, NLRP12, FAP, DLC1, BAX, MNDA, PDCD1, LTBR]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[BECN1, PCNA, NCF1, ATP2A2, PARK7, PTPRK, PKD2, RELA, AQP1, PRDX1, ALDH3B1, TP53INP1, ABL1, ECT2, PPARGC1B, MAP3K5, SLC25A24, G6PD, ANXA1, PNPT1, GPX3, TXNRD1, PRKCD, GPX7, PYCR1, VRK2, EIF2S1, SIRT2, RHOB, MAPK13, DNM2, SOD1, SETX, NR4A2, IL6, CCS, PXMP2, CDK2, CAT, PPIF, NFE2L1, EZH2]
GO:0070534;protein K63-linked ubiquitination;11.0;0.9326813400603323;0.8987696223598284;9.577230958104572;157.60047254366168;6.166155715036245;0.00527474598481953;0.747766442352181;[ITCH, UBE2B, UBE2T, UBE2E3, NEDD4, ZFP91, TRIM27]
GO:0016266;O-glycan processing;9.0;0.7866048967936545;0.7895430735771163;9.277126365654233;178.64096908048714;5.666199763507158;0.0059789524686895724;0.6860103445912811;[GALNT12, GALNT11, ST6GAL1, B3GNT8, GALNT1, ST3GAL1, GALNT10]
GO:0030311;poly-N-acetyllactosamine biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;809.9795361789301;7.474488534686424;0.027109286141652648;0.7331650565203278;[B3GNT8]
GO:0031643;positive regulation of myelination;7.0;1.0;0.8509193652572005;9.628524252492122;206.47068931946234;7.212124270218933;0.006910388159965925;0.7197477358342742;[DICER1]
